Introduction	Introduction	NNP	0
c-fo	c-fo	NN	B-NP
is	is	VBZ	0
a	a	DT	0
member	member	NN	0
of	of	IN	0
the	the	DT	0
family	family	NN	0
of	of	IN	0
immediate	immediate	JJ	0
early	early	JJ	0
genes	genes	NNS	0
,	,	,	0
and	and	CC	0
its	its	PRP$	0
transcription	transcription	NN	B-NP
is	is	VBZ	0
transiently	transiently	VBN	0
induced	induced	VBN	0
in	in	IN	0
response	response	NN	0
to	to	TO	0
mitogenic	mitogenic	VB	0
signals	signals	NNS	0
[	[	-LRB-	0
1	1	LS	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
serum	serum	JJ	B-NP
response	response	NN	I-NP
element	element	NN	I-NP
(	(	-LRB-	0
SRE	SRE	NNP	B-NP
)	)	-RRB-	0
is	is	VBZ	0
located	located	VBN	0
approximately	approximately	RB	0
300	300	CD	0
bp	bp	JJ	0
upstream	upstream	NN	0
of	of	IN	0
the	the	DT	0
transcriptional	transcriptional	JJ	B-NP
start	start	NN	I-NP
site	site	NN	I-NP
in	in	IN	0
the	the	DT	0
c-fos	c-fos	JJ	B-NP
promoter	promoter	NN	I-NP
and	and	CC	0
is	is	VBZ	0
necessary	necessary	JJ	0
for	for	IN	0
c-fo	c-fo	NN	B-NP
serum	serum	JJ	I-NP
induction	induction	NN	I-NP
[	[	-LRB-	0
2	2	LS	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
serum	serum	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
response	response	NN	I-NP
element	element	NN	I-NP
binds	binds	VBD	0
a	a	DT	0
named	named	VBN	B-NP
serum	serum	JJ	I-NP
response	response	NN	I-NP
factor	factor	NN	I-NP
transcription	transcription	JJ	I-NP
factor	factor	NN	I-NP
(	(	-LRB-	0
SRF	SRF	NNP	B-NP
)	)	-RRB-	0
which	which	WDT	0
was	was	VBD	0
found	found	VBN	0
to	to	TO	0
be	be	VB	0
necessary	necessary	JJ	0
,	,	,	0
but	but	CC	0
not	not	RB	0
sufficient	sufficient	JJ	0
,	,	,	0
for	for	IN	0
serum	serum	JJ	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
response	response	NN	I-NP
element	element	NN	I-NP
serum	serum	JJ	I-NP
induction	induction	NN	I-NP
[	[	-LRB-	0
3	3	LS	0
,	,	,	0
4	4	CD	0
,	,	,	0
5	5	CD	0
]	]	-RRB-	0
.	.	.	0
In	In	IN	0
vivo	vivo	JJ	B-NP
footprinting	footprinting	JJ	I-NP
analysis	analysis	NN	I-NP
show	show	NN	I-NP
that	that	IN	0
serum	serum	NN	B-NP
response	response	NN	I-NP
factor	factor	NN	I-NP
is	is	VBZ	0
constitutively	constitutively	VBN	0
bound	bound	VBN	0
to	to	TO	0
the	the	DT	0
serum	serum	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
response	response	NN	I-NP
element	element	NN	I-NP
in	in	IN	0
both	both	DT	0
quiescent	quiescent	NN	0
and	and	CC	0
growth	growth	NN	B-NP
factor	factor	NN	I-NP
stimulated	stimulated	NN	I-NP
cell	cell	NN	I-NP
[	[	-LRB-	0
6	6	CD	0
]	]	-RRB-	0
.	.	.	0
This	This	DT	0
suggests	suggests	VBZ	0
that	that	IN	0
it	it	PRP	0
is	is	VBZ	0
the	the	DT	0
transcriptional	transcriptional	JJ	B-NP
activation	activation	NN	I-NP
of	of	IN	0
a	a	DT	0
complex	complex	NN	0
of	of	IN	0
serum	serum	NN	B-NP
response	response	NN	I-NP
factor	factor	NN	I-NP
and	and	CC	0
its	its	PRP$	0
accessory	accessory	JJ	B-NP
protein	protein	NN	I-NP
that	that	WDT	0
is	is	VBZ	0
regulated	regulated	VBN	0
rather	rather	RB	0
than	than	IN	0
regulation	regulation	NN	0
of	of	IN	0
SRF	SRF	NNP	B-NP
DNA	DNA	NNP	I-NP
binding	binding	NN	I-NP
.	.	.	0
The	The	DT	0
ternary	ternary	JJ	B-NP
complex	complex	JJ	I-NP
factor	factor	NN	I-NP
(	(	-LRB-	0
TCFs	TCFs	NNP	B-NP
)	)	-RRB-	0
are	are	VBP	0
members	members	NNS	0
of	of	IN	0
the	the	DT	0
transcription	transcription	JJ	B-NP
factor	factor	NN	I-NP
ets	ets	JJ	I-NP
family	family	NN	I-NP
.	.	.	0
The	The	DT	0
elk-1	elk-1	NN	B-NP
tcf	tcf	NN	I-NP
family	family	NN	I-NP
member	member	NN	I-NP
[	[	-LRB-	0
7	7	CD	0
]	]	-RRB-	0
,	,	,	0
SAP-1	SAP-1	NNP	B-NP
[	[	-LRB-	0
8	8	CD	0
]	]	-RRB-	0
,	,	,	0
and	and	CC	0
SAP-2	SAP-2	NNP	B-NP
/	/	NNP	0
ERP	ERP	NNP	B-NP
/	/	NNP	I-NP
NET	NET	NNP	I-NP
[	[	-LRB-	0
9	9	CD	0
,	,	,	0
10	10	CD	0
]	]	-RRB-	0
have	have	VBP	0
been	been	VBN	0
found	found	VBN	0
to	to	TO	0
have	have	VB	0
a	a	DT	0
role	role	NN	0
in	in	IN	0
regulating	regulating	VBG	0
the	the	DT	0
serum	serum	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
response	response	NN	I-NP
element	element	NN	I-NP
.	.	.	0
TCFs	TCFs	JJ	0
cannot	cannot	NNS	0
bind	bind	VBP	0
the	the	DT	0
serum	serum	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
response	response	NN	I-NP
element	element	NN	I-NP
autonomously	autonomously	NN	0
,	,	,	0
but	but	CC	0
require	require	VB	0
protein-protein	protein-protein	JJ	B-NP
interaction	interaction	NN	I-NP
with	with	IN	0
serum	serum	NN	B-NP
response	response	NN	I-NP
factor	factor	NN	I-NP
in	in	IN	0
order	order	NN	0
to	to	TO	0
bind	bind	VB	0
the	the	DT	0
serum	serum	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
response	response	NN	I-NP
element	element	NN	I-NP
[	[	-LRB-	0
11	11	CD	0
,	,	,	0
12	12	CD	0
,	,	,	0
13	13	CD	0
,	,	,	0
14	14	CD	0
,	,	,	0
15	15	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
TCFs	TCFs	JJ	0
contain	contain	NN	0
3	3	CD	0
conserved	conserved	CD	0
motifs	motifs	NNS	0
termed	termed	VBD	0
the	the	DT	0
A	A	NNP	0
,	,	,	0
B	B	NNP	0
,	,	,	0
and	and	CC	0
C	C	NNP	0
boxes	boxes	NNS	0
[	[	-LRB-	0
16	16	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
N-terminal	N-terminal	JJ	B-NP
A-box	A-box	NN	I-NP
(	(	-LRB-	0
amino	amino	JJ	B-NP
acid	acid	NN	I-NP
(	(	-LRB-	0
amino	amino	JJ	B-NP
acid	acid	NN	I-NP
)	)	-RRB-	0
1-90	1-90	CD	0
of	of	IN	0
Elk-1	Elk-1	CD	B-NP
)	)	-RRB-	0
is	is	VBZ	0
necessary	necessary	JJ	0
to	to	TO	0
bind	bind	VB	0
DNA	DNA	NNP	B-NP
,	,	,	0
while	while	IN	0
the	the	DT	0
central	central	JJ	0
B-box	B-box	NN	B-NP
(	(	-LRB-	0
amino	amino	JJ	B-NP
acid	acid	NN	I-NP
148-168	148-168	FW	0
)	)	-RRB-	0
is	is	VBZ	0
the	the	DT	0
SRF	SRF	NNP	B-NP
interaction	interaction	JJ	I-NP
domain	domain	NN	I-NP
.	.	.	0
The	The	DT	0
C-terminal	C-terminal	JJ	B-NP
C-box	C-box	NN	I-NP
(	(	-LRB-	0
amino	amino	JJ	B-NP
acid	acid	NN	I-NP
352-399	352-399	FW	0
)	)	-RRB-	0
,	,	,	0
harboring	harboring	VBG	0
the	the	DT	0
transactivation	transactivation	JJ	B-NP
domain	domain	NN	I-NP
,	,	,	0
contains	contains	VBZ	0
several	several	JJ	0
activated	activated	VBN	B-NP
protein	protein	NN	I-NP
kinase	kinase	NN	I-NP
consensus	consensus	NN	I-NP
mitogen	mitogen	NN	I-NP
(	(	-LRB-	0
map	map	NN	B-NP
kinase	kinase	NN	I-NP
)	)	-RRB-	0
phosphorylation	phosphorylation	JJ	B-NP
site	site	NN	I-NP
.	.	.	0
Accordingly	Accordingly	RB	0
,	,	,	0
the	the	DT	0
ternary	ternary	NN	B-NP
complex	complex	JJ	I-NP
factor	factor	NN	I-NP
have	have	VBP	0
been	been	VBN	0
found	found	VBN	0
to	to	TO	0
be	be	VB	0
targets	targets	NNS	0
of	of	IN	0
the	the	DT	0
Ras-Raf-MAPK	Ras-Raf-MAPK	JJ	B-NP
signal	signal	NN	I-NP
transduction	transduction	NN	I-NP
pathway	pathway	NN	I-NP
[	[	-LRB-	0
16	16	CD	0
]	]	-RRB-	0
.	.	.	0
In	In	IN	0
addition	addition	NN	B-NP
,	,	,	0
the	the	DT	0
ternary	ternary	NN	B-NP
complex	complex	JJ	I-NP
factor	factor	NN	I-NP
have	have	VBP	0
been	been	VBN	0
found	found	VBN	0
to	to	TO	0
be	be	VB	0
targets	targets	NNS	0
for	for	IN	0
all	all	DT	0
three	three	CD	0
families	families	NNS	0
of	of	IN	0
MAPKs	MAPKs	JJ	0
:	:	:	0
the	the	DT	0
extracellular	extracellular	JJ	B-NP
signal-regulated	signal-regulated	JJ	I-NP
kinas	kinas	NNP	I-NP
1	1	CD	0
/	/	CD	0
2	2	CD	0
(	(	-LRB-	0
ERK1	ERK1	CD	B-NP
/	/	CD	I-NP
2	2	CD	I-NP
)	)	-RRB-	0
,	,	,	0
the	the	DT	0
activated	activated	VBN	B-NP
protein	protein	NN	I-NP
kinas	kinas	NNP	I-NP
jun-n-terminal	jun-n-terminal	NN	I-NP
kinases/stres	kinases/stres	NN	I-NP
(	(	-LRB-	0
JNK	JNK	NNP	B-NP
/	/	NNP	I-NP
SAPK	SAPK	NNP	I-NP
)	)	-RRB-	0
,	,	,	0
and	and	CC	0
the	the	DT	0
p38	p38	CD	B-NP
kinasa	kinasa	NN	I-NP
[	[	-LRB-	0
17	17	CD	0
,	,	,	0
18	18	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
ternary	ternary	NN	B-NP
complex	complex	JJ	I-NP
factor	factor	NN	I-NP
transcriptional	transcriptional	JJ	I-NP
activity	activity	NN	I-NP
are	are	VBP	0
stimulated	stimulated	VBN	0
by	by	IN	0
c-terminal	c-terminal	NN	B-NP
mapk	mapk	NN	I-NP
site	site	NN	I-NP
phosphorylation	phosphorylation	NN	I-NP
[	[	-LRB-	0
16	16	CD	0
,	,	,	0
17	17	CD	0
]	]	-RRB-	0
.	.	.	0
Another	Another	DT	0
transcription	transcription	JJ	B-NP
factor	factor	NN	I-NP
that	that	WDT	0
is	is	VBZ	0
involved	involved	VBN	0
in	in	IN	0
regulation	regulation	NN	0
of	of	IN	0
the	the	DT	0
c-fos	c-fos	JJ	B-NP
SRE	SRE	NNP	I-NP
is	is	VBZ	0
CCAAT	CCAAT	NNP	B-NP
/	/	FW	0
Enhancer	Enhancer	FW	0
binding	binding	JJ	B-NP
protein-beta	protein-beta	NN	I-NP
(	(	-LRB-	0
C	C	NNP	B-NP
/	/	NNP	I-NP
EBPβ	EBPβ	NNP	I-NP
)	)	-RRB-	0
.	.	.	0
ccaat/enhancer	ccaat/enhancer	NN	B-NP
binding	binding	JJ	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
protein	protein	NN	I-NP
beta	beta	NN	I-NP
(	(	-LRB-	0
also	also	RB	0
known	known	VBN	0
as	as	IN	0
NF-IL6	NF-IL6	NNP	B-NP
,	,	,	0
LAP	LAP	NNP	0
,	,	,	0
NF-M	NF-M	NNP	B-NP
,	,	,	0
AGP	AGP	NNP	B-NP
/	/	NNP	I-NP
EBP	EBP	NNP	I-NP
,	,	,	0
and	and	CC	0
CRP2	CRP2	CD	B-NP
)	)	-RRB-	0
is	is	VBZ	0
a	a	DT	0
member	member	NN	0
of	of	IN	0
the	the	DT	0
transcription	transcription	JJ	B-NP
factor	factor	NN	I-NP
basic-leucine	basic-leucine	JJ	I-NP
zipper	zipper	JJ	I-NP
family	family	NN	I-NP
[	[	-LRB-	0
19	19	CD	0
,	,	,	0
20	20	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
C	C	NNP	B-NP
/	/	NNP	I-NP
EBPβ	EBPβ	NNP	I-NP
mRNA	mRNA	NNP	I-NP
contains	contains	VBZ	0
three	three	CD	0
in-frame	in-frame	JJ	B-NP
methionine	methionine	NN	I-NP
which	which	WDT	0
give	give	VBP	0
rise	rise	NN	0
to	to	TO	0
three	three	CD	0
different	different	JJ	0
translation	translation	NN	B-NP
product	product	NN	I-NP
:	:	:	0
p38	p38	CD	B-NP
,	,	,	0
p35	p35	NNP	B-NP
,	,	,	0
and	and	CC	0
p20-C	p20-C	NNP	B-NP
/	/	NNP	I-NP
EBPβ	EBPβ	NNP	I-NP
[	[	-LRB-	0
21	21	CD	0
]	]	-RRB-	0
.	.	.	0
p38	p38	NN	B-NP
and	and	CC	0
p35-C	p35-C	NNP	B-NP
/	/	NNP	I-NP
EBPβ	EBPβ	NNP	I-NP
both	both	CC	0
contain	contain	VB	0
an	an	DT	0
N-terminal	N-terminal	JJ	B-NP
transactivation	transactivation	JJ	I-NP
domain	domain	NN	I-NP
and	and	CC	0
a	a	DT	0
C-terminal	C-terminal	JJ	B-NP
DNA	DNA	NNP	I-NP
binding	binding	JJ	I-NP
/	/	NN	I-NP
dimerization	dimerization	NN	I-NP
domain.	domain.	NN	I-NP
p20-C	p20-C	NN	B-NP
/	/	NN	I-NP
EBPβ	EBPβ	NN	I-NP
lacks	lacks	VBZ	0
the	the	DT	0
N-terminal	N-terminal	JJ	B-NP
transactivation	transactivation	JJ	I-NP
domain	domain	NN	I-NP
and	and	CC	0
therefore	therefore	RB	0
acts	acts	VBZ	0
as	as	IN	0
a	a	DT	0
transcription	transcription	NN	B-NP
repressor	repressor	NN	I-NP
.	.	.	0
Our	Our	PRP$	0
lab	lab	NN	0
has	has	VBZ	0
previously	previously	RB	0
shown	shown	VBN	0
that	that	IN	0
p35-C	p35-C	NNP	B-NP
/	/	NNP	I-NP
EBPβ	EBPβ	NNP	I-NP
activates	activates	VBD	0
an	an	DT	0
SRE-driven	SRE-driven	JJ	B-NP
reporter	reporter	NN	I-NP
construct	construct	NN	0
while	while	IN	0
p20-C	p20-C	CD	B-NP
/	/	CD	I-NP
EBPβ	EBPβ	JJ	I-NP
inhibits	inhibits	JJ	0
serum	serum	JJ	B-NP
stimulation	stimulation	NN	I-NP
of	of	IN	0
the	the	DT	0
same	same	JJ	0
reporter	reporter	NN	0
[	[	-LRB-	0
22	22	CD	0
]	]	-RRB-	0
.	.	.	0
We	We	PRP	0
have	have	VBP	0
also	also	RB	0
shown	shown	VBN	0
that	that	IN	0
both	both	DT	0
p35-C	p35-C	NNP	B-NP
/	/	NNP	I-NP
EBPβ	EBPβ	NNP	I-NP
and	and	CC	0
p20-C	p20-C	NNP	B-NP
/	/	NNP	I-NP
EBPβ	EBPβ	NNP	I-NP
could	could	MD	0
interact	interact	VB	0
with	with	IN	0
serum	serum	NN	B-NP
response	response	NN	I-NP
factor	factor	NN	I-NP
in	in	IN	0
vivo	vivo	NN	B-NP
and	and	CC	0
that	that	IN	0
the	the	DT	0
interaction	interaction	NN	0
between	between	IN	0
serum	serum	NN	B-NP
response	response	NN	I-NP
factor	factor	NN	I-NP
and	and	CC	0
p35-C	p35-C	NNP	B-NP
/	/	NNP	I-NP
EBPβ	EBPβ	NNP	I-NP
,	,	,	0
but	but	CC	0
not	not	RB	0
between	between	IN	0
serum	serum	NN	B-NP
response	response	NN	I-NP
factor	factor	NN	I-NP
and	and	CC	0
p20-C	p20-C	NNP	B-NP
/	/	NNP	I-NP
EBPβ	EBPβ	NNP	I-NP
,	,	,	0
is	is	VBZ	0
stimulated	stimulated	VBN	0
by	by	IN	0
activated	activated	JJ	0
Ras	Ras	NNP	0
.	.	.	0
The	The	DT	0
target	target	NN	0
for	for	IN	0
this	this	DT	0
Ras	Ras	JJ	B-NP
stimulation	stimulation	NN	I-NP
is	is	VBZ	0
Thr235	Thr235	CD	B-NP
in	in	IN	0
a	a	DT	0
consensus	consensus	NN	B-NP
MAPK	MAPK	NNP	I-NP
site	site	NN	I-NP
in	in	IN	0
ccaat/enhancer	ccaat/enhancer	NN	B-NP
binding	binding	JJ	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
protein	protein	NN	I-NP
beta	beta	NN	I-NP
[	[	-LRB-	0
23	23	CD	0
]	]	-RRB-	0
.	.	.	0
Therefore	Therefore	RB	0
,	,	,	0
ccaat/enhancer	ccaat/enhancer	NN	B-NP
binding	binding	JJ	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
protein	protein	NN	I-NP
beta	beta	NN	I-NP
is	is	VBZ	0
a	a	DT	0
target	target	NN	0
of	of	IN	0
a	a	DT	0
Ras-dependent	Ras-dependent	JJ	B-NP
signaling	signaling	JJ	0
pathway	pathway	NN	0
that	that	WDT	0
regulates	regulates	VBZ	0
its	its	PRP$	0
interaction	interaction	NN	0
with	with	IN	0
serum	serum	NN	B-NP
response	response	NN	I-NP
factor	factor	NN	I-NP
.	.	.	0
Based	Based	VBN	0
on	on	IN	0
the	the	DT	0
observation	observation	NN	B-NP
that	that	IN	0
tcf	tcf	NN	B-NP
factor	factor	NN	I-NP
as	as	IN	0
well	well	RB	0
as	as	IN	0
p35-C	p35-C	NNP	B-NP
/	/	NNP	I-NP
EBPβ	EBPβ	NNP	I-NP
:	:	:	0
(	(	-LRB-	0
1	1	LS	0
)	)	-RRB-	0
interact	interact	NN	0
with	with	IN	0
serum	serum	NN	B-NP
response	response	NN	I-NP
factor	factor	NN	I-NP
(	(	-LRB-	0
2	2	LS	0
)	)	-RRB-	0
transactivate	transactivate	VBZ	0
the	the	DT	0
serum	serum	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
response	response	NN	I-NP
element	element	NN	I-NP
and	and	CC	0
(	(	-LRB-	0
3	3	LS	0
)	)	-RRB-	0
are	are	VBP	0
responsive	responsive	JJ	0
to	to	TO	0
Ras-dependent	Ras-dependent	JJ	B-NP
signaling	signaling	JJ	0
pathways	pathways	NN	0
,	,	,	0
we	we	PRP	0
tested	tested	VBD	0
the	the	DT	0
possibility	possibility	NN	0
that	that	IN	0
both	both	DT	0
TCF	TCF	NNP	B-NP
and	and	CC	0
p35-C	p35-C	CD	B-NP
/	/	CD	I-NP
EBPβ	EBPβ	NN	I-NP
are	are	VBP	0
necessary	necessary	JJ	0
for	for	IN	0
serum	serum	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
response	response	NN	I-NP
element	element	NN	I-NP
maximal	maximal	JJ	I-NP
induction	induction	NN	I-NP
in	in	IN	0
response	response	NN	0
to	to	TO	0
mitogenic	mitogenic	VB	0
stimulation	stimulation	NN	0
.	.	.	0
In	In	IN	0
this	this	DT	0
study	study	NN	0
,	,	,	0
we	we	PRP	0
show	show	VBP	0
that	that	IN	0
p35-C	p35-C	NNP	B-NP
/	/	NNP	I-NP
EBPβ	EBPβ	NNP	I-NP
and	and	CC	0
the	the	DT	0
TCF	TCF	NNP	B-NP
family	family	NN	I-NP
member	member	NN	I-NP
Elk-1	Elk-1	CD	I-NP
synergize	synergize	NN	I-NP
in	in	IN	0
serum	serum	NN	B-NP
response	response	NN	I-NP
factor	factor	NN	I-NP
transactivation	transactivation	NN	I-NP
dependent	dependent	JJ	0
transcription	transcription	NN	B-NP
of	of	IN	0
both	both	PDT	0
a	a	DT	0
Gal4	Gal4	JJ	B-NP
dependent	dependent	JJ	I-NP
reporter	reporter	NN	I-NP
and	and	CC	0
an	an	DT	0
SRE-driven	SRE-driven	JJ	B-NP
reporter	reporter	NN	I-NP
construct	construct	NN	0
,	,	,	0
but	but	CC	0
only	only	RB	0
in	in	IN	0
response	response	NN	0
to	to	TO	0
mitogenic	mitogenic	VB	0
stimulation	stimulation	VBN	0
by	by	IN	0
Ras	Ras	NNP	0
.	.	.	0
We	We	PRP	0
further	further	RB	0
show	show	VB	0
that	that	IN	0
Elk-1	Elk-1	NNP	B-NP
and	and	CC	0
p35-C	p35-C	CD	B-NP
/	/	CD	I-NP
EBPβ	EBPβ	JJ	I-NP
interact	interact	NN	0
in	in	IN	0
vitro	vitro	NN	B-NP
in	in	IN	0
a	a	DT	0
glutathione-S-transferase	glutathione-S-transferase	JJ	B-NP
(	(	-LRB-	I-NP
GST	GST	NNP	I-NP
)	)	-RRB-	I-NP
-pulldown	-pulldown	JJ	I-NP
assay	assay	NN	I-NP
as	as	IN	0
well	well	RB	0
as	as	RB	0
in	in	IN	0
an	an	DT	0
in	in	FW	0
vivo	vivo	NNP	B-NP
coimmunoprecipitation	coimmunoprecipitation	NN	I-NP
assay	assay	NN	I-NP
.	.	.	0
The	The	DT	0
in	in	IN	0
vivo	vivo	JJ	B-NP
interaction	interaction	NN	I-NP
is	is	VBZ	0
dependent	dependent	JJ	0
on	on	IN	0
the	the	DT	0
presence	presence	NN	0
of	of	IN	0
activated	activated	JJ	0
Ras	Ras	NNP	0
.	.	.	0
Finally	Finally	RB	0
,	,	,	0
we	we	PRP	0
show	show	VBP	0
that	that	IN	0
the	the	DT	0
ccaat/enhancer	ccaat/enhancer	NN	B-NP
binding	binding	JJ	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
protein	protein	NN	I-NP
beta	beta	NN	I-NP
c-terminal	c-terminal	NN	I-NP
domain	domain	NN	I-NP
is	is	VBZ	0
sufficient	sufficient	JJ	0
to	to	TO	0
interact	interact	VB	0
with	with	IN	0
Elk-1	Elk-1	CD	B-NP
while	while	IN	0
the	the	DT	0
elk-1	elk-1	NN	B-NP
n-terminal	n-terminal	NN	I-NP
a-box	a-box	NN	I-NP
is	is	VBZ	0
necessary	necessary	JJ	0
to	to	TO	0
interact	interact	VB	0
with	with	IN	0
ccaat/enhancer	ccaat/enhancer	NN	B-NP
binding	binding	JJ	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
protein	protein	NN	I-NP
beta	beta	NN	I-NP
.	.	.	0
These	These	DT	0
results	results	NNS	0
suggest	suggest	VBP	0
a	a	DT	0
cooperative	cooperative	JJ	B-NP
role	role	NN	I-NP
between	between	IN	0
the	the	DT	0
TCF	TCF	NNP	B-NP
and	and	CC	0
c/ebpβ	c/ebpβ	NN	B-NP
transcription	transcription	JJ	I-NP
factor	factor	NN	I-NP
in	in	IN	0
regulation	regulation	NN	0
of	of	IN	0
the	the	DT	0
c-fos	c-fos	JJ	B-NP
SRE	SRE	NN	I-NP
in	in	IN	0
response	response	NN	0
to	to	TO	0
Ras-dependent	Ras-dependent	JJ	B-NP
signaling	signaling	JJ	0
pathways	pathways	NN	0
.	.	.	0
Results	Results	NNP	0
Elk-1	Elk-1	NNP	B-NP
and	and	CC	0
p35-C	p35-C	CD	B-NP
/	/	CD	I-NP
EBPβ	EBPβ	JJ	I-NP
synergize	synergize	NN	I-NP
in	in	IN	0
gal4	gal4	NN	B-NP
dependent	dependent	JJ	I-NP
reporter	reporter	NN	I-NP
transactivation	transactivation	NN	I-NP
Due	Due	JJ	0
to	to	TO	0
the	the	DT	0
common	common	JJ	0
observation	observation	NN	B-NP
that	that	IN	0
both	both	DT	0
Elk-1	Elk-1	NNP	B-NP
and	and	CC	0
p35-C	p35-C	NNP	B-NP
/	/	NNP	I-NP
EBPβ	EBPβ	NNP	I-NP
transactivate	transactivate	VBD	0
the	the	DT	0
serum	serum	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
response	response	NN	I-NP
element	element	NN	I-NP
,	,	,	0
interact	interact	VBG	0
with	with	IN	0
serum	serum	NN	B-NP
response	response	NN	I-NP
factor	factor	NN	I-NP
,	,	,	0
and	and	CC	0
are	are	VBP	0
responsive	responsive	JJ	0
to	to	TO	0
Ras-dependent	Ras-dependent	JJ	B-NP
signaling	signaling	JJ	0
pathways	pathways	NN	0
,	,	,	0
we	we	PRP	0
hypothesized	hypothesized	VBD	0
that	that	IN	0
Elk-1	Elk-1	NNP	B-NP
and	and	CC	0
p35-C	p35-C	NNP	B-NP
/	/	NNP	I-NP
EBPβ	EBPβ	NNP	I-NP
may	may	MD	0
both	both	RB	0
be	be	VB	0
necessary	necessary	JJ	0
for	for	IN	0
serum	serum	NN	B-NP
response	response	NN	I-NP
factor	factor	NN	I-NP
maximal	maximal	JJ	I-NP
induction	induction	NN	I-NP
dependent	dependent	JJ	0
transcription	transcription	NN	B-NP
.	.	.	0
To	To	TO	0
begin	begin	VB	0
to	to	TO	0
test	test	VB	0
this	this	DT	0
hypothesis	hypothesis	NN	0
,	,	,	0
we	we	PRP	0
used	used	VBD	0
a	a	DT	0
GAL4	GAL4	JJ	B-NP
dependent	dependent	JJ	I-NP
reporter	reporter	NN	I-NP
construct	construct	NN	0
,	,	,	0
in	in	IN	0
which	which	WDT	0
a	a	DT	0
CAT	CAT	NNP	0
reporter	reporter	NN	0
gene	gene	NN	0
is	is	VBZ	0
driven	driven	VBN	0
by	by	IN	0
five	five	CD	0
copies	copies	NNS	0
of	of	IN	0
a	a	DT	0
GAL4	GAL4	JJ	B-NP
binding	binding	JJ	I-NP
site	site	NN	I-NP
upstream	upstream	NN	0
of	of	IN	0
the	the	DT	0
adenovirus	adenovirus	FW	0
E1B	E1B	FW	0
minimal	minimal	FW	0
promoter	promoter	FW	0
(	(	-LRB-	0
pG5CAT	pG5CAT	NNP	0
)	)	-RRB-	0
.	.	.	0
We	We	PRP	0
constructed	constructed	VBD	0
a	a	DT	0
GAL4	GAL4	NNP	B-NP
DNA	DNA	NNP	I-NP
binding	binding	JJ	0
domain-SRF	domain-SRF	JJ	B-NP
fusion	fusion	NN	I-NP
protein	protein	NN	I-NP
,	,	,	0
as	as	RB	0
has	has	VBZ	0
been	been	VBN	0
described	described	VBN	0
previously	previously	RB	0
[	[	-LRB-	0
23	23	CD	0
]	]	-RRB-	0
.	.	.	0
GAL4-SRF	GAL4-SRF	NNP	B-NP
binds	binds	VBD	0
to	to	TO	0
the	the	DT	0
GAL4	GAL4	JJ	B-NP
reporter	reporter	NN	I-NP
construct	construct	NN	0
,	,	,	0
thereby	thereby	RB	0
reporter	reporter	NN	B-NP
gene	gene	NN	I-NP
dependent	dependent	NN	I-NP
making	making	VBG	I-NP
transcription	transcription	NN	I-NP
on	on	IN	0
the	the	DT	0
presence	presence	NN	0
of	of	IN	0
serum	serum	NN	B-NP
response	response	NN	I-NP
factor	factor	NN	I-NP
.	.	.	0
As	As	RB	0
shown	shown	VBN	0
in	in	IN	0
Fig.	Fig.	CD	0
1	1	CD	0
,	,	,	0
when	when	WRB	0
a	a	DT	0
GAL4-SRF	GAL4-SRF	JJ	B-NP
fusion	fusion	NN	I-NP
construct	construct	NN	0
is	is	VBZ	0
transfected	transfected	VBN	0
with	with	IN	0
the	the	DT	0
reporter	reporter	NN	0
,	,	,	0
there	there	EX	0
is	is	VBZ	0
no	no	DT	0
increase	increase	NN	0
in	in	IN	0
CAT	CAT	NNP	0
activity	activity	NN	0
.	.	.	0
The	The	DT	0
SRF	SRF	NNP	B-NP
transactivation	transactivation	JJ	I-NP
domain	domain	NN	I-NP
is	is	VBZ	0
weak	weak	JJ	0
,	,	,	0
as	as	RB	0
has	has	VBZ	0
been	been	VBN	0
shown	shown	VBN	0
previously	previously	RB	0
[	[	-LRB-	0
24	24	CD	0
]	]	-RRB-	0
.	.	.	0
When	When	WRB	0
CMV-Elk-1	CMV-Elk-1	NNP	B-NP
is	is	VBZ	0
cotransfected	cotransfected	VBN	0
with	with	IN	0
the	the	DT	0
reporter	reporter	NN	0
and	and	CC	0
GAL4-SRF	GAL4-SRF	NNP	B-NP
,	,	,	0
there	there	EX	0
is	is	VBZ	0
little	little	JJ	0
increase	increase	NN	0
in	in	IN	0
CAT	CAT	NNP	0
activity	activity	NN	0
in	in	IN	0
the	the	DT	0
absence	absence	NN	B-NP
of	of	IN	0
activated	activated	JJ	0
Ras	Ras	NNP	0
(	(	-LRB-	0
cmv-ra	cmv-ra	NN	B-NP
)	)	-RRB-	0
.	.	.	0
This	This	DT	0
result	result	NN	0
is	is	VBZ	0
expected	expected	VBN	0
since	since	IN	0
the	the	DT	0
elk-1	elk-1	NN	B-NP
transactivation	transactivation	JJ	I-NP
domain	domain	NN	I-NP
is	is	VBZ	0
activated	activated	VBN	0
in	in	IN	0
response	response	NN	0
to	to	TO	0
Ras	Ras	NNP	0
.	.	.	0
Therefore	Therefore	RB	0
,	,	,	0
when	when	WRB	0
activated	activated	JJ	0
Ras	Ras	NNP	0
is	is	VBZ	0
transfected	transfected	VBN	0
with	with	IN	0
Elk-1	Elk-1	NNP	B-NP
,	,	,	0
GAL4-SRF	GAL4-SRF	NNP	B-NP
,	,	,	0
and	and	CC	0
the	the	DT	0
reporter	reporter	NN	0
,	,	,	0
the	the	DT	0
CAT	CAT	NNP	0
activity	activity	NN	0
increases	increases	NNS	0
to	to	TO	0
8-fold	8-fold	CD	0
over	over	IN	0
basal	basal	JJ	B-NP
level	level	JJ	I-NP
.	.	.	0
We	We	PRP	0
cannot	cannot	RB	0
determine	determine	VB	0
if	if	IN	0
the	the	DT	0
increase	increase	NN	0
in	in	IN	0
CAT	CAT	NNP	0
activity	activity	NN	0
in	in	IN	0
the	the	DT	0
presence	presence	NN	0
of	of	IN	0
Ras	Ras	NNP	0
also	also	RB	0
reflects	reflects	VBZ	0
a	a	DT	0
stimulation	stimulation	NN	0
of	of	IN	0
the	the	DT	0
interaction	interaction	NN	0
of	of	IN	0
the	the	DT	0
Elk-1	Elk-1	NNP	B-NP
and	and	CC	0
srf	srf	NN	B-NP
protein	protein	NN	I-NP
.	.	.	0
When	When	WRB	0
CMV-LAP	CMV-LAP	JJ	B-NP
(	(	-LRB-	0
which	which	WDT	0
encodes	encodes	VBZ	0
p35-C	p35-C	NNP	B-NP
/	/	NNP	I-NP
EBPβ	EBPβ	NNP	I-NP
)	)	-RRB-	0
is	is	VBZ	0
transfected	transfected	VBN	0
with	with	IN	0
GAL4-SRF	GAL4-SRF	NNP	B-NP
and	and	CC	0
the	the	DT	0
reporter	reporter	NN	0
construct	construct	NN	0
,	,	,	0
we	we	PRP	0
see	see	VBP	0
a	a	DT	0
7-fold	7-fold	JJ	0
increase	increase	NN	0
in	in	IN	0
CAT	CAT	NNP	0
activity	activity	NN	0
that	that	WDT	0
is	is	VBZ	0
potentiated	potentiated	VBN	0
to	to	TO	0
75-fold	75-fold	CD	0
when	when	WRB	0
activated	activated	JJ	0
Ras	Ras	NNP	0
is	is	VBZ	0
cotransfected	cotransfected	VBN	0
.	.	.	0
Therefore	Therefore	RB	0
,	,	,	0
c/ebpβ	c/ebpβ	NN	B-NP
result	result	NN	I-NP
in	in	IN	0
a	a	DT	0
much	much	RB	0
larger	larger	JJR	0
increase	increase	NN	0
in	in	IN	0
transcription	transcription	NN	B-NP
than	than	IN	0
Elk-1	Elk-1	CD	B-NP
.	.	.	0
We	We	PRP	0
have	have	VBP	0
previously	previously	RB	0
shown	shown	VBN	0
that	that	IN	0
Ras	Ras	NNP	0
does	does	VBZ	0
not	not	RB	0
activate	activate	VBP	0
the	the	DT	0
p35-c/ebpβ	p35-c/ebpβ	NN	B-NP
transactivation	transactivation	JJ	I-NP
domain	domain	NN	I-NP
[	[	-LRB-	0
23	23	CD	0
]	]	-RRB-	0
.	.	.	0
Thus	Thus	RB	0
,	,	,	0
the	the	DT	0
increase	increase	NN	0
in	in	IN	0
transcription	transcription	NN	B-NP
in	in	IN	0
this	this	DT	0
assay	assay	NN	B-NP
is	is	VBZ	0
due	due	JJ	0
to	to	TO	0
srf-p35-c/ebpβ	srf-p35-c/ebpβ	NN	B-NP
interaction	interaction	NN	I-NP
ras	ras	NNP	I-NP
stimulation	stimulation	NN	I-NP
.	.	.	0
Interestingly	Interestingly	RB	0
,	,	,	0
when	when	WRB	0
all	all	DT	0
three	three	CD	0
constructs	constructs	NNS	0
-	-	:	0
serum	serum	NN	B-NP
response	response	NN	I-NP
factor	factor	NN	I-NP
,	,	,	0
Elk-1	Elk-1	NNP	B-NP
,	,	,	0
and	and	CC	0
p35-C	p35-C	CD	B-NP
/	/	CD	I-NP
EBPβ-are	EBPβ-are	JJ	I-NP
cotransfected	cotransfected	NN	I-NP
with	with	IN	0
the	the	DT	0
reporter	reporter	NN	0
construct	construct	NN	0
,	,	,	0
there	there	EX	0
is	is	VBZ	0
an	an	DT	0
average	average	JJ	0
260-fold	260-fold	CD	0
increase	increase	NN	0
in	in	IN	0
CAT	CAT	NNP	0
activity	activity	NN	0
in	in	IN	0
the	the	DT	0
presence	presence	NN	0
of	of	IN	0
activated	activated	JJ	0
Ras	Ras	NNP	0
.	.	.	0
The	The	DT	0
values	values	NNS	0
of	of	IN	0
fold	fold	NN	B-NP
activation	activation	VBP	I-NP
varied	varied	VBN	0
from	from	IN	0
as	as	IN	0
low	low	JJ	0
as	as	IN	0
60-fold	60-fold	CD	0
to	to	TO	0
as	as	RB	0
high	high	JJ	0
as	as	IN	0
725-fold	725-fold	CD	0
over	over	IN	0
basal	basal	JJ	B-NP
level	level	JJ	I-NP
,	,	,	0
and	and	CC	0
we	we	PRP	0
are	are	VBP	0
unsure	unsure	VBN	0
of	of	IN	0
the	the	DT	0
reason	reason	NN	0
for	for	IN	0
this	this	DT	0
variability	variability	NN	0
.	.	.	0
However	However	RB	0
,	,	,	0
regardless	regardless	RB	0
of	of	IN	0
the	the	DT	0
extent	extent	NN	0
of	of	IN	0
activation	activation	NN	B-NP
,	,	,	0
in	in	IN	0
every	every	DT	0
experiment	experiment	NN	0
there	there	EX	0
was	was	VBD	0
a	a	DT	0
synergy	synergy	NN	B-NP
observed	observed	VBD	0
when	when	WRB	0
both	both	DT	0
Elk-1	Elk-1	NNP	B-NP
and	and	CC	0
p35-C	p35-C	CD	B-NP
/	/	CD	I-NP
EBPβ	EBPβ	NN	I-NP
are	are	VBP	0
transfected	transfected	VBN	0
in	in	IN	0
the	the	DT	0
presence	presence	NN	0
of	of	IN	0
Ras	Ras	NNP	0
.	.	.	0
There	There	EX	0
is	is	VBZ	0
only	only	RB	0
a	a	DT	0
slight	slight	JJ	0
increase	increase	NN	0
in	in	IN	0
CAT	CAT	NNP	0
activity	activity	NN	0
in	in	IN	0
the	the	DT	0
absence	absence	NN	B-NP
of	of	IN	0
Ras	Ras	NNP	0
.	.	.	0
Therefore	Therefore	RB	0
,	,	,	0
Elk-1	Elk-1	NNP	B-NP
and	and	CC	0
p35-C	p35-C	CD	B-NP
/	/	CD	I-NP
EBPβ	EBPβ	NN	I-NP
are	are	VBP	0
working	working	VBG	0
synergistically	synergistically	NN	0
to	to	TO	0
transactivate	transactivate	VB	0
the	the	DT	0
reporter	reporter	NN	0
construct	construct	NN	0
in	in	IN	0
the	the	DT	0
presence	presence	NN	0
of	of	IN	0
serum	serum	NN	B-NP
response	response	NN	I-NP
factor	factor	NN	I-NP
.	.	.	0
This	This	DT	0
synergism	synergism	NN	B-NP
is	is	VBZ	0
only	only	RB	0
observed	observed	VBN	0
in	in	IN	0
response	response	NN	0
to	to	TO	0
mitogenic	mitogenic	JJ	B-NP
signaling	signaling	JJ	I-NP
pathway	pathway	NN	I-NP
activation	activation	VB	I-NP
by	by	IN	0
Ras	Ras	NNP	0
.	.	.	0
Elk-1	Elk-1	NNP	B-NP
and	and	CC	0
p35-C	p35-C	CD	B-NP
/	/	CD	I-NP
EBPβ	EBPβ	JJ	I-NP
synergize	synergize	NN	I-NP
in	in	IN	0
serum	serum	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
response	response	NN	I-NP
element	element	NN	I-NP
transactivation	transactivation	NN	I-NP
Since	Since	IN	0
Elk-1	Elk-1	NNP	B-NP
and	and	CC	0
p35-C	p35-C	CD	B-NP
/	/	CD	I-NP
EBPβ	EBPβ	JJ	I-NP
synergize	synergize	NN	I-NP
in	in	IN	0
srf-dependent	srf-dependent	NN	B-NP
transcription	transcription	NNS	I-NP
transactivation	transactivation	NN	I-NP
using	using	VBG	0
a	a	DT	0
GAL4-dependent	GAL4-dependent	JJ	B-NP
promoter	promoter	NN	I-NP
,	,	,	0
we	we	PRP	0
next	next	RB	0
tested	tested	VBN	0
if	if	IN	0
Elk-1	Elk-1	NNP	B-NP
and	and	CC	0
p35-C	p35-C	NNP	B-NP
/	/	NNP	I-NP
EBPβ	EBPβ	NNP	I-NP
could	could	MD	0
also	also	RB	0
synergize	synergize	VBN	0
in	in	IN	0
transactivation	transactivation	NN	B-NP
of	of	IN	0
a	a	DT	0
native	native	JJ	0
serum	serum	NN	B-NP
response	response	NN	I-NP
factor	factor	NN	I-NP
binding	binding	JJ	0
site	site	NN	0
,	,	,	0
namely	namely	RB	0
the	the	DT	0
c-fos	c-fos	JJ	B-NP
SRE	SRE	NNP	I-NP
.	.	.	0
To	To	TO	0
test	test	VB	0
this	this	DT	0
possibility	possibility	NN	0
,	,	,	0
NIH	NIH	NNP	B-NP
3T3	3T3	NNP	0
cells	cells	NNS	0
were	were	VBD	0
transiently	transiently	JJ	0
transfected	transfected	NN	B-NP
with	with	IN	0
a	a	DT	0
CAT	CAT	NNP	0
reporter	reporter	NN	0
gene	gene	NN	0
driven	driven	VBN	0
by	by	IN	0
one	one	CD	0
copy	copy	NN	0
of	of	IN	0
the	the	DT	0
wild	wild	JJ	0
type	type	NN	B-NP
SRE	SRE	NNP	I-NP
upstream	upstream	NN	0
of	of	IN	0
the	the	DT	0
Rous	Rous	JJ	0
sarcoma	sarcoma	JJ	B-NP
virus	virus	NN	I-NP
long	long	JJ	0
terminal	terminal	NN	B-NP
repeat	repeat	NN	I-NP
minimal	minimal	JJ	0
promoter	promoter	NN	0
.	.	.	0
As	As	RB	0
shown	shown	VBN	0
in	in	IN	0
Fig.	Fig.	CD	0
2	2	CD	0
,	,	,	0
when	when	WRB	0
p35-C	p35-C	NNP	B-NP
/	/	NNP	I-NP
EBPβ	EBPβ	NNP	I-NP
is	is	VBZ	0
co-transfected	co-transfected	JJ	B-NP
with	with	IN	0
the	the	DT	0
reporter	reporter	NN	0
construct	construct	NN	0
,	,	,	0
there	there	EX	0
is	is	VBZ	0
a	a	DT	0
13-fold	13-fold	JJ	0
increase	increase	NN	0
in	in	IN	0
CAT	CAT	NNP	0
activity	activity	NN	0
in	in	IN	0
the	the	DT	0
absence	absence	NN	B-NP
of	of	IN	0
activated	activated	JJ	0
Ras	Ras	NNS	0
that	that	WDT	0
is	is	VBZ	0
increased	increased	VBN	0
to	to	TO	0
24-fold	24-fold	CD	0
when	when	WRB	0
cmv-ra	cmv-ra	NN	B-NP
is	is	VBZ	0
co-transfected	co-transfected	JJ	B-NP
.	.	.	0
When	When	WRB	0
CMV-Elk-1	CMV-Elk-1	NNP	B-NP
is	is	VBZ	0
co-transfected	co-transfected	JJ	B-NP
with	with	IN	0
the	the	DT	0
SRE	SRE	NNP	B-NP
reporter	reporter	NN	I-NP
construct	construct	NN	0
,	,	,	0
there	there	EX	0
is	is	VBZ	0
no	no	DT	0
additional	additional	JJ	0
stimulation	stimulation	NN	0
in	in	IN	0
transactivation	transactivation	NN	B-NP
in	in	IN	0
either	either	RB	0
the	the	DT	0
absence	absence	NN	B-NP
or	or	CC	0
presence	presence	NN	0
of	of	IN	0
Ras	Ras	NNP	0
compared	compared	VBN	0
to	to	TO	0
the	the	DT	0
reporter	reporter	NN	0
alone	alone	RB	0
.	.	.	0
However	However	RB	0
,	,	,	0
when	when	WRB	0
both	both	DT	0
Elk-1	Elk-1	NNP	B-NP
and	and	CC	0
p35-C	p35-C	CD	B-NP
/	/	CD	I-NP
EBPβ	EBPβ	NN	I-NP
are	are	VBP	0
transfected	transfected	VBN	0
with	with	IN	0
the	the	DT	0
SRE	SRE	NNP	B-NP
reporter	reporter	NN	I-NP
construct	construct	NN	0
,	,	,	0
there	there	EX	0
is	is	VBZ	0
a	a	DT	0
synergistic	synergistic	JJ	B-NP
effect	effect	NN	I-NP
in	in	IN	0
serum	serum	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
response	response	NN	I-NP
element	element	NN	I-NP
transactivation	transactivation	NN	I-NP
,	,	,	0
with	with	IN	0
a	a	DT	0
72-fold	72-fold	JJ	0
increase	increase	NN	0
in	in	IN	0
CAT	CAT	NNP	0
activity	activity	NN	0
over	over	IN	0
reporter	reporter	NN	0
construct	construct	VBZ	0
alone	alone	RB	0
.	.	.	0
As	As	RB	0
was	was	VBD	0
seen	seen	VBN	0
with	with	IN	0
the	the	DT	0
Gal4	Gal4	JJ	B-NP
reporter	reporter	NN	I-NP
,	,	,	0
this	this	DT	0
synergism	synergism	NN	B-NP
is	is	VBZ	0
only	only	RB	0
observed	observed	VBN	0
in	in	IN	0
the	the	DT	0
presence	presence	NN	0
of	of	IN	0
activated	activated	JJ	0
Ras	Ras	NNP	0
.	.	.	0
These	These	DT	0
data	data	NNS	0
suggest	suggest	VBP	0
that	that	IN	0
both	both	DT	0
Elk-1	Elk-1	NNP	B-NP
and	and	CC	0
p35-C	p35-C	CD	B-NP
/	/	CD	I-NP
EBPβ	EBPβ	NN	I-NP
are	are	VBP	0
necessary	necessary	JJ	0
for	for	IN	0
serum	serum	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
response	response	NN	I-NP
element	element	NN	I-NP
maximal	maximal	JJ	I-NP
ras-stimulated	ras-stimulated	NN	I-NP
transactivation	transactivation	NN	I-NP
.	.	.	0
The	The	DT	0
TCF	TCF	NNP	B-NP
family	family	NN	I-NP
member	member	NN	I-NP
Elk-1	Elk-1	NN	I-NP
and	and	CC	0
ccaat/enhancer	ccaat/enhancer	NN	B-NP
binding	binding	JJ	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
protein	protein	NN	I-NP
beta	beta	NN	I-NP
interact	interact	NN	0
in	in	IN	0
vitro	vitro	VBG	B-NP
We	We	PRP	0
next	next	RB	0
tested	tested	VBN	0
the	the	DT	0
possibility	possibility	NN	0
that	that	IN	0
there	there	EX	0
could	could	MD	0
be	be	VB	0
a	a	DT	0
direct	direct	JJ	0
protein-protein	protein-protein	JJ	B-NP
interaction	interaction	NN	I-NP
between	between	IN	0
Elk-1	Elk-1	NNP	B-NP
and	and	CC	0
p35-C	p35-C	CD	B-NP
/	/	CD	I-NP
EBPβ	EBPβ	NN	I-NP
based	based	VBN	0
on	on	IN	0
the	the	DT	0
fact	fact	NN	0
that	that	IN	0
they	they	PRP	0
synergize	synergize	VBD	0
in	in	IN	0
serum	serum	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
response	response	NN	I-NP
element	element	NN	I-NP
transactivation	transactivation	NN	I-NP
.	.	.	0
Therefore	Therefore	RB	0
,	,	,	0
we	we	PRP	0
used	used	VBD	0
a	a	DT	0
GST-pulldown	GST-pulldown	JJ	B-NP
assay	assay	NN	I-NP
to	to	TO	0
determine	determine	VB	0
if	if	IN	0
the	the	DT	0
proteins	proteins	NNS	0
could	could	MD	0
interact	interact	VB	0
in	in	IN	0
vitro	vitro	NN	B-NP
.	.	.	0
p35-C	p35-C	NN	B-NP
/	/	NN	I-NP
EBPβ	EBPβ	NNP	I-NP
was	was	VBD	0
expressed	expressed	VBN	0
as	as	IN	0
a	a	DT	0
chimeric	chimeric	JJ	B-NP
GST	GST	NNP	I-NP
protein	protein	NN	I-NP
and	and	CC	0
immobilized	immobilized	NN	0
on	on	IN	0
glutathione-agarose	glutathione-agarose	JJ	B-NP
bead	bead	NN	I-NP
.	.	.	0
Beads	Beads	FW	0
containing	containing	VBG	B-NP
GST-p35-C	GST-p35-C	NN	I-NP
/	/	NN	I-NP
EBPβ	EBPβ	NN	I-NP
or	or	CC	0
gstorc4	gstorc4	NN	B-NP
alone	alone	RB	0
were	were	VBD	0
incubated	incubated	VBN	0
with	with	IN	0
in	in	IN	0
vitro	vitro	JJ	B-NP
-translated	-translated	JJ	0
Elk-1	Elk-1	NN	0
labeled	labeled	VBN	0
with	with	IN	0
[	[	-LRB-	0
35S	35S	NNP	0
]	]	-RRB-	0
methionine	methionine	NN	B-NP
.	.	.	0
As	As	RB	0
shown	shown	VBN	0
in	in	IN	0
Fig.	Fig.	CD	0
3	3	CD	0
,	,	,	0
lane	lane	CD	0
2	2	CD	0
,	,	,	0
approximately	approximately	RB	0
35-45	35-45	CD	0
%	%	NN	0
of	of	IN	0
the	the	DT	0
input	input	NN	B-NP
Elk-1	Elk-1	NN	I-NP
was	was	VBD	0
retained	retained	VBN	0
on	on	IN	0
the	the	DT	0
gst-p35-c/ebpβ	gst-p35-c/ebpβ	NN	B-NP
bead	bead	NN	I-NP
.	.	.	0
A	A	DT	0
small	small	JJ	0
amount	amount	NN	0
of	of	IN	0
Elk-1	Elk-1	CD	B-NP
bound	bound	VBN	0
to	to	TO	0
the	the	DT	0
beads	beads	NN	0
containing	containing	VBG	B-NP
GST	GST	NNP	I-NP
alone	alone	RB	0
(	(	-LRB-	0
Fig.	Fig.	CD	0
3	3	CD	0
,	,	,	0
lane	lane	CD	0
3	3	CD	0
)	)	-RRB-	0
which	which	WDT	0
we	we	PRP	0
have	have	VBP	0
been	been	VBN	0
unable	unable	JJ	0
to	to	TO	0
eliminate	eliminate	VB	0
even	even	RB	0
after	after	IN	0
blocking	blocking	VBG	0
with	with	IN	0
unprogrammed	unprogrammed	JJ	B-NP
translation	translation	NN	I-NP
lysate	lysate	NN	I-NP
.	.	.	0
However	However	RB	0
,	,	,	0
it	it	PRP	0
is	is	VBZ	0
clear	clear	JJ	0
that	that	IN	0
the	the	DT	0
binding	binding	NN	0
of	of	IN	0
Elk-1	Elk-1	NNP	B-NP
is	is	VBZ	0
substantially	substantially	RB	0
increased	increased	VBN	0
when	when	WRB	0
the	the	DT	0
GST-p35-C	GST-p35-C	CD	B-NP
/	/	CD	I-NP
EBPβ	EBPβ	JJ	I-NP
fusion	fusion	NN	I-NP
protein	protein	NN	I-NP
is	is	VBZ	0
present	present	JJ	0
on	on	IN	0
the	the	DT	0
beads	beads	NN	0
.	.	.	0
These	These	DT	0
data	data	NNS	0
indicate	indicate	VBP	0
that	that	IN	0
Elk-1	Elk-1	NNP	B-NP
and	and	CC	0
p35-C	p35-C	CD	B-NP
/	/	CD	I-NP
EBPβ	EBPβ	NN	I-NP
are	are	VBP	0
capable	capable	JJ	0
of	of	IN	0
interacting	interacting	NN	0
in	in	IN	0
vitro	vitro	NN	B-NP
.	.	.	0
Elk-1	Elk-1	NNP	B-NP
and	and	CC	0
p35-C	p35-C	CD	B-NP
/	/	CD	I-NP
EBPβ	EBPβ	JJ	I-NP
interact	interact	NN	0
in	in	IN	0
vivo	vivo	NN	B-NP
,	,	,	0
but	but	CC	0
only	only	RB	0
in	in	IN	0
the	the	DT	0
presence	presence	NN	0
of	of	IN	0
activated	activated	JJ	0
Ras	Ras	NNS	0
Since	Since	IN	0
we	we	PRP	0
observed	observed	VBD	0
an	an	DT	0
in	in	IN	0
vitro	vitro	JJ	B-NP
interaction	interaction	NN	I-NP
between	between	IN	0
the	the	DT	0
Elk-1	Elk-1	NNP	B-NP
and	and	CC	0
c/ebpβ	c/ebpβ	NN	B-NP
protein	protein	NN	I-NP
,	,	,	0
we	we	PRP	0
next	next	RB	0
tested	tested	VBN	0
whether	whether	IN	0
the	the	DT	0
proteins	proteins	NNS	0
could	could	MD	0
interact	interact	VB	0
in	in	IN	0
vivo	vivo	NN	B-NP
as	as	IN	0
well	well	RB	0
.	.	.	0
To	To	TO	0
do	do	VB	0
this	this	DT	0
,	,	,	0
we	we	PRP	0
used	used	VBD	0
a	a	DT	0
co-immunoprecipitation	co-immunoprecipitation	JJ	B-NP
approach	approach	NN	I-NP
.	.	.	0
cos-7	cos-7	NN	B-NP
cell	cell	NN	I-NP
were	were	VBD	0
transfected	transfected	VBN	0
with	with	IN	0
an	an	DT	0
expression	expression	NN	B-NP
vector	vector	NN	I-NP
for	for	IN	0
a	a	DT	0
6X	6X	FW	0
histidine	histidine	FW	0
tagged	tagged	FW	0
construct	construct	FW	0
of	of	IN	0
p35-C	p35-C	CD	B-NP
/	/	CD	I-NP
EBPβ	EBPβ	JJ	I-NP
carrying	carrying	VBG	0
the	the	DT	0
φ	φ	JJ	0
10	10	CD	0
(	(	-LRB-	0
T7	T7	NNP	B-NP
tag	tag	NN	I-NP
)	)	-RRB-	0
epitope	epitope	JJ	B-NP
sequence	sequence	NN	I-NP
either	either	CC	0
in	in	IN	0
the	the	DT	0
presence	presence	NN	0
or	or	CC	0
elk-1	elk-1	NN	B-NP
absence	absence	NN	I-NP
.	.	.	0
cell	cell	NN	B-NP
lysate	lysate	NN	I-NP
were	were	VBD	0
incubated	incubated	VBN	0
with	with	IN	0
t7	t7	NN	B-NP
tag	tag	NN	I-NP
ab	ab	NN	I-NP
agarose	agarose	NN	I-NP
bead	bead	NN	I-NP
followed	followed	VBN	0
by	by	IN	0
immunoblotting	immunoblotting	NN	B-NP
of	of	IN	0
the	the	DT	0
precipitated	precipitated	JJ	0
proteins	proteins	NNS	0
with	with	IN	0
Elk-1	Elk-1	NNP	B-NP
Ab	Ab	NNP	I-NP
.	.	.	0
As	As	RB	0
shown	shown	VBN	0
in	in	IN	0
Fig.	Fig.	CD	0
4	4	CD	0
,	,	,	0
there	there	EX	0
is	is	VBZ	0
no	no	DT	0
Elk-1	Elk-1	JJ	B-NP
protein	protein	NN	I-NP
precipitated	precipitated	VBD	0
with	with	IN	0
the	the	DT	0
tagged	tagged	JJ	0
C	C	$	B-NP
/	/	CD	I-NP
EBPβ	EBPβ	JJ	I-NP
protein	protein	NN	I-NP
when	when	WRB	0
both	both	DT	0
are	are	VBP	0
transfected	transfected	NN	B-NP
(	(	-LRB-	0
lane	lane	CD	0
5	5	CD	0
)	)	-RRB-	0
.	.	.	0
However	However	RB	0
,	,	,	0
since	since	IN	0
the	the	DT	0
elk-1	elk-1	NN	B-NP
synergism	synergism	NN	I-NP
and	and	CC	0
p35-C	p35-C	NNP	B-NP
/	/	NNP	I-NP
EBPβ	EBPβ	NNP	I-NP
is	is	VBZ	0
observed	observed	VBN	0
when	when	WRB	0
activated	activated	JJ	0
Ras	Ras	NNP	0
is	is	VBZ	0
present	present	JJ	0
,	,	,	0
we	we	PRP	0
thought	thought	VBD	0
it	it	PRP	0
likely	likely	RB	0
that	that	IN	0
the	the	DT	0
interaction	interaction	NN	0
between	between	IN	0
the	the	DT	0
two	two	CD	0
proteins	proteins	NNS	0
could	could	MD	0
be	be	VB	0
Ras-dependent	Ras-dependent	JJ	B-NP
.	.	.	0
Indeed	Indeed	RB	0
,	,	,	0
when	when	WRB	0
activated	activated	JJ	0
Ras	Ras	NNP	0
is	is	VBZ	0
co-transfected	co-transfected	JJ	B-NP
along	along	IN	0
with	with	IN	0
Elk-1	Elk-1	NNP	B-NP
and	and	CC	0
histidine-tagged	histidine-tagged	NNP	B-NP
p35-C	p35-C	NNP	I-NP
/	/	NNP	I-NP
EBPβ	EBPβ	NNP	I-NP
,	,	,	0
the	the	DT	0
Elk-1	Elk-1	JJ	B-NP
protein	protein	NN	I-NP
is	is	VBZ	0
precipitated	precipitated	VBN	0
with	with	IN	0
the	the	DT	0
p35-C	p35-C	NNP	B-NP
/	/	NNP	I-NP
EBPβ	EBPβ	NNP	I-NP
(	(	-LRB-	0
lane	lane	CD	0
6	6	CD	0
)	)	-RRB-	0
.	.	.	0
One	One	CD	0
possible	possible	JJ	0
explanation	explanation	NN	0
for	for	IN	0
this	this	DT	0
result	result	NN	0
is	is	VBZ	0
that	that	IN	0
Ras	Ras	NNP	0
increases	increases	VBZ	0
the	the	DT	0
amount	amount	NN	0
of	of	IN	0
p35-C	p35-C	NNP	B-NP
/	/	NNP	I-NP
EBPβ	EBPβ	NNP	I-NP
or	or	CC	0
Elk-1	Elk-1	CD	B-NP
protein	protein	NN	I-NP
in	in	IN	0
the	the	DT	0
cos-7	cos-7	NN	B-NP
cell	cell	NN	I-NP
,	,	,	0
but	but	CC	0
Western	Western	JJ	0
blot	blot	JJ	0
analysis	analysis	NN	0
showed	showed	VBD	0
that	that	IN	0
both	both	DT	0
p35-C	p35-C	NNP	B-NP
/	/	NNP	I-NP
EBPβ	EBPβ	NNP	I-NP
and	and	CC	0
elk-1	elk-1	NN	B-NP
protein	protein	NN	I-NP
level	level	JJ	I-NP
are	are	VBP	0
the	the	DT	0
same	same	JJ	0
in	in	IN	0
the	the	DT	0
absence	absence	NN	B-NP
and	and	CC	0
presence	presence	NN	0
of	of	IN	0
Ras	Ras	NNP	0
(	(	-LRB-	0
data	data	NNS	0
not	not	RB	0
shown	shown	VBN	0
)	)	-RRB-	0
.	.	.	0
Therefore	Therefore	RB	0
,	,	,	0
p35-C	p35-C	NNP	B-NP
/	/	NNP	I-NP
EBPβ	EBPβ	NNP	I-NP
and	and	CC	0
Elk-1	Elk-1	CD	B-NP
interact	interact	NN	0
in	in	IN	0
vivo	vivo	NN	B-NP
,	,	,	0
but	but	CC	0
only	only	RB	0
in	in	IN	0
response	response	NN	0
to	to	TO	0
ras-dependent	ras-dependent	NN	B-NP
activation	activation	VB	I-NP
signaling	signaling	JJ	0
pathways	pathways	NN	0
.	.	.	0
The	The	DT	0
ccaat/enhancer	ccaat/enhancer	NN	B-NP
binding	binding	JJ	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
protein	protein	NN	I-NP
beta	beta	NN	I-NP
c-terminal	c-terminal	NN	I-NP
domain	domain	NN	I-NP
is	is	VBZ	0
necessary	necessary	JJ	0
to	to	TO	0
interact	interact	VB	0
with	with	IN	0
Elk-1	Elk-1	CD	B-NP
in	in	IN	0
vitro	vitro	NN	B-NP
Since	Since	IN	0
ccaat/enhancer	ccaat/enhancer	NN	B-NP
binding	binding	JJ	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
protein	protein	NN	I-NP
beta	beta	NN	I-NP
and	and	CC	0
Elk-1	Elk-1	CD	B-NP
interact	interact	NN	0
,	,	,	0
we	we	PRP	0
next	next	RB	0
wanted	wanted	VBD	0
to	to	TO	0
narrow	narrow	VB	0
down	down	RP	0
the	the	DT	0
domains	domains	NN	0
of	of	IN	0
the	the	DT	0
proteins	proteins	NNS	0
that	that	WDT	0
are	are	VBP	0
required	required	VBN	0
for	for	IN	0
their	their	PRP$	0
interaction	interaction	NN	0
.	.	.	0
To	To	TO	0
determine	determine	VB	0
the	the	DT	0
domain	domain	NN	0
of	of	IN	0
ccaat/enhancer	ccaat/enhancer	NN	B-NP
binding	binding	JJ	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
protein	protein	NN	I-NP
beta	beta	NN	I-NP
that	that	WDT	0
is	is	VBZ	0
necessary	necessary	JJ	0
to	to	TO	0
interact	interact	VB	0
with	with	IN	0
Elk-1	Elk-1	NNP	B-NP
,	,	,	0
a	a	DT	0
p20-C	p20-C	CD	B-NP
/	/	CD	I-NP
EBPβ-GST	EBPβ-GST	JJ	I-NP
fusion	fusion	NN	I-NP
protein	protein	NN	I-NP
was	was	VBD	0
constructed.	constructed.	CD	0
p20-C	p20-C	CD	B-NP
/	/	CD	I-NP
EBPβ	EBPβ	JJ	I-NP
encodes	encodes	NNS	0
the	the	DT	0
20	20	CD	0
ccaat/enhancer	ccaat/enhancer	NN	B-NP
binding	binding	JJ	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
protein	protein	NN	I-NP
beta	beta	NN	I-NP
kda	kda	NN	I-NP
form	form	NN	I-NP
,	,	,	0
which	which	WDT	0
lacks	lacks	VBZ	0
the	the	DT	0
N-terminal	N-terminal	JJ	B-NP
transactivation	transactivation	JJ	I-NP
domain	domain	NN	I-NP
of	of	IN	0
the	the	DT	0
longer	longer	RB	0
p35-C	p35-C	CD	B-NP
/	/	CD	I-NP
EBPβ	EBPβ	JJ	I-NP
isoform	isoform	NN	I-NP
.	.	.	0
This	This	DT	0
isoform	isoform	NN	B-NP
,	,	,	0
however	however	RB	0
,	,	,	0
shares	shares	NNS	0
the	the	DT	0
C-terminal	C-terminal	JJ	B-NP
DNA	DNA	NN	I-NP
binding	binding	NNS	0
and	and	CC	0
dimerization	dimerization	JJ	B-NP
domain	domain	NN	I-NP
with	with	IN	0
p35-C	p35-C	NNP	B-NP
/	/	NNP	I-NP
EBPβ	EBPβ	NNP	I-NP
.	.	.	0
As	As	RB	0
shown	shown	VBN	0
in	in	IN	0
Fig.	Fig.	CD	0
5	5	CD	0
,	,	,	0
approximately	approximately	RB	0
the	the	DT	0
same	same	JJ	0
amount	amount	NN	0
of	of	IN	0
[	[	-LRB-	0
35S	35S	NNP	0
]	]	-RRB-	0
-labeled	-labeled	NNP	0
Elk-1	Elk-1	NNP	B-NP
is	is	VBZ	0
retained	retained	VBN	0
on	on	IN	0
both	both	PDT	0
the	the	DT	0
GST-p20-C	GST-p20-C	NNP	B-NP
/	/	NNP	I-NP
EBPβ	EBPβ	NNP	I-NP
and	and	CC	0
gst-p35-c/ebpβ	gst-p35-c/ebpβ	NN	B-NP
bead	bead	NN	I-NP
(	(	-LRB-	0
compare	compare	VB	0
lanes	lanes	CD	0
2	2	CD	0
and	and	CC	0
3	3	LS	0
)	)	-RRB-	0
.	.	.	0
Therefore	Therefore	RB	0
,	,	,	0
deletion	deletion	NN	0
of	of	IN	0
the	the	DT	0
ccaat/enhancer	ccaat/enhancer	NN	B-NP
binding	binding	JJ	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
protein	protein	NN	I-NP
beta	beta	NN	I-NP
n-terminus	n-terminus	NN	I-NP
has	has	VBZ	0
no	no	DT	0
effect	effect	NN	0
on	on	IN	0
its	its	PRP$	0
ability	ability	NN	B-NP
to	to	TO	0
interact	interact	VB	0
with	with	IN	0
Elk-1	Elk-1	CD	B-NP
.	.	.	0
This	This	DT	0
data	data	NN	0
demonstrates	demonstrates	VBZ	0
that	that	IN	0
the	the	DT	0
ccaat/enhancer	ccaat/enhancer	NN	B-NP
binding	binding	JJ	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
protein	protein	NN	I-NP
beta	beta	NN	I-NP
c-terminal	c-terminal	NN	I-NP
region	region	NN	I-NP
is	is	VBZ	0
sufficient	sufficient	JJ	0
to	to	TO	0
mediate	mediate	VB	0
interaction	interaction	VBN	0
with	with	IN	0
Elk-1	Elk-1	CD	B-NP
in	in	IN	0
vitro	vitro	NN	B-NP
.	.	.	0
The	The	DT	0
elk-1	elk-1	NN	B-NP
n-terminal	n-terminal	NN	I-NP
a-box	a-box	NN	I-NP
is	is	VBZ	0
sufficient	sufficient	JJ	0
to	to	TO	0
interact	interact	VB	0
with	with	IN	0
ccaat/enhancer	ccaat/enhancer	NN	B-NP
binding	binding	JJ	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
protein	protein	NN	I-NP
beta	beta	NN	I-NP
in	in	IN	0
vitro	vitro	NN	B-NP
In	In	IN	0
order	order	NN	0
to	to	TO	0
narrow	narrow	VB	0
down	down	RP	0
the	the	DT	0
domain	domain	NN	0
of	of	IN	0
Elk-1	Elk-1	NNP	B-NP
that	that	WDT	0
is	is	VBZ	0
necessary	necessary	JJ	0
to	to	TO	0
interact	interact	VB	0
with	with	IN	0
ccaat/enhancer	ccaat/enhancer	NN	B-NP
binding	binding	JJ	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
protein	protein	NN	I-NP
beta	beta	NN	I-NP
in	in	IN	0
vitro	vitro	NN	B-NP
,	,	,	0
we	we	PRP	0
made	made	VBD	0
several	several	JJ	0
elk-1	elk-1	NN	B-NP
deletion	deletion	NN	I-NP
mutant	mutant	NN	I-NP
(	(	-LRB-	0
Fig.	Fig.	NNP	0
6A	6A	NNP	0
)	)	-RRB-	0
and	and	CC	0
tested	tested	VBD	0
these	these	DT	0
constructs	constructs	NN	0
in	in	IN	0
a	a	DT	0
pulldown	pulldown	JJ	B-NP
assay	assay	NN	I-NP
with	with	IN	0
GST-p35-C	GST-p35-C	NNP	B-NP
/	/	NNP	I-NP
EBPβ	EBPβ	NNP	I-NP
.	.	.	0
Elk-1	Elk-1	NNP	B-NP
(	(	-LRB-	I-NP
1-209	1-209	NNP	I-NP
)	)	-RRB-	I-NP
is	is	VBZ	0
a	a	DT	0
C-terminal	C-terminal	JJ	B-NP
deletion	deletion	NN	I-NP
mutant	mutant	NN	I-NP
that	that	WDT	0
lacks	lacks	VBZ	0
the	the	DT	0
C-box	C-box	JJ	B-NP
.	.	.	0
Elk-1	Elk-1	NNP	B-NP
(	(	-LRB-	I-NP
1-140	1-140	NNP	I-NP
)	)	-RRB-	I-NP
is	is	VBZ	0
also	also	RB	0
a	a	DT	0
C-terminal	C-terminal	JJ	B-NP
deletion	deletion	NN	I-NP
,	,	,	0
but	but	CC	0
it	it	PRP	0
lacks	lacks	VBZ	0
both	both	PDT	0
the	the	DT	0
B-	B-	JJ	0
and	and	CC	0
c-box	c-box	NN	B-NP
.	.	.	0
Therefore	Therefore	RB	0
,	,	,	0
this	this	DT	0
mutant	mutant	NN	B-NP
contains	contains	VBZ	0
neither	neither	RB	0
a	a	DT	0
transactivation	transactivation	JJ	B-NP
domain	domain	NN	I-NP
nor	nor	CC	0
an	an	DT	0
serum	serum	NN	B-NP
response	response	NN	I-NP
factor	factor	NN	I-NP
binding	binding	JJ	0
domain	domain	NN	0
.	.	.	0
Finally	Finally	RB	0
,	,	,	0
Elk-1	Elk-1	NNP	B-NP
(	(	-LRB-	I-NP
89-428	89-428	NNP	I-NP
)	)	-RRB-	I-NP
is	is	VBZ	0
a	a	DT	0
deletion	deletion	NN	0
of	of	IN	0
the	the	DT	0
N-terminal	N-terminal	JJ	B-NP
A-box	A-box	NN	I-NP
.	.	.	0
containing	containing	VBG	B-NP
gst-p35-c/ebpβ	gst-p35-c/ebpβ	NN	I-NP
glutathione	glutathione	NN	I-NP
agarose	agarose	NN	I-NP
bead	bead	NN	I-NP
or	or	CC	0
gstorc4	gstorc4	NN	B-NP
alone	alone	RB	0
were	were	VBD	0
incubated	incubated	VBN	0
with	with	IN	0
in	in	IN	0
vitro	vitro	JJ	B-NP
-translated	-translated	JJ	0
Elk-1	Elk-1	NN	0
mutants	mutants	VBZ	0
labeled	labeled	VBN	0
with	with	IN	0
[	[	-LRB-	0
35S	35S	NNP	0
]	]	-RRB-	0
methionine	methionine	NN	B-NP
.	.	.	0
As	As	RB	0
shown	shown	VBN	0
in	in	IN	0
Fig.	Fig.	CD	0
6B	6B	CD	0
,	,	,	0
the	the	DT	0
c-terminal	c-terminal	NN	B-NP
elk-1	elk-1	NN	I-NP
mutant	mutant	NN	I-NP
,	,	,	0
Elk-1	Elk-1	NNP	B-NP
(	(	-LRB-	I-NP
1-209	1-209	NNP	I-NP
)	)	-RRB-	I-NP
and	and	CC	0
Elk-1	Elk-1	NNP	B-NP
(	(	-LRB-	I-NP
1-140	1-140	NNP	I-NP
)	)	-RRB-	I-NP
,	,	,	0
bound	bound	VBN	0
to	to	TO	0
the	the	DT	0
gst-p35-c/ebpβ	gst-p35-c/ebpβ	NN	B-NP
bead	bead	NN	I-NP
to	to	TO	0
the	the	DT	0
same	same	JJ	0
extent	extent	NN	0
as	as	IN	0
wild-type	wild-type	NNP	B-NP
Elk-1	Elk-1	NNP	I-NP
(	(	-LRB-	0
compare	compare	VB	0
lane	lane	CD	0
3	3	CD	0
of	of	IN	0
top	top	JJ	0
3	3	CD	0
panels	panels	NNS	0
)	)	-RRB-	0
.	.	.	0
However	However	RB	0
,	,	,	0
the	the	DT	0
A-box	A-box	JJ	B-NP
deletion	deletion	JJ	I-NP
mutant	mutant	NN	I-NP
,	,	,	0
Elk-1	Elk-1	NNP	B-NP
(	(	-LRB-	I-NP
89-428	89-428	NNP	I-NP
)	)	-RRB-	I-NP
,	,	,	0
no	no	DT	0
longer	longer	RBR	0
binds	binds	JJ	0
to	to	TO	0
the	the	DT	0
GST-p35-C	GST-p35-C	NNP	B-NP
/	/	NNP	I-NP
EBPβ	EBPβ	NNP	I-NP
(	(	-LRB-	0
lane	lane	CD	0
3	3	CD	0
,	,	,	0
bottom	bottom	JJ	0
panel	panel	NN	0
)	)	-RRB-	0
.	.	.	0
Therefore	Therefore	RB	0
,	,	,	0
this	this	DT	0
data	data	NN	0
demonstrates	demonstrates	VBZ	0
that	that	IN	0
the	the	DT	0
elk-1	elk-1	NN	B-NP
a-box	a-box	NN	I-NP
is	is	VBZ	0
necessary	necessary	JJ	0
to	to	TO	0
interact	interact	VB	0
with	with	IN	0
ccaat/enhancer	ccaat/enhancer	NN	B-NP
binding	binding	JJ	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
protein	protein	NN	I-NP
beta	beta	NN	I-NP
in	in	IN	0
vitro	vitro	NN	B-NP
.	.	.	0
Discussion	Discussion	NN	0
We	We	PRP	0
have	have	VBP	0
shown	shown	VBN	0
that	that	IN	0
the	the	DT	0
elk-1	elk-1	NN	B-NP
transcription	transcription	JJ	I-NP
factor	factor	NN	I-NP
and	and	CC	0
p35-C	p35-C	CD	B-NP
/	/	CD	I-NP
EBPβ	EBPβ	JJ	I-NP
synergize	synergize	NN	I-NP
in	in	IN	0
srf-dependent	srf-dependent	NN	B-NP
transcription	transcription	NNS	I-NP
transactivation	transactivation	NN	I-NP
using	using	VBG	0
both	both	DT	0
GAL4	GAL4	NNP	B-NP
and	and	CC	0
SRE-driven	SRE-driven	JJ	B-NP
reporter	reporter	NN	I-NP
constructs	constructs	NN	0
.	.	.	0
Interestingly	Interestingly	RB	0
,	,	,	0
this	this	DT	0
synergy	synergy	NN	B-NP
is	is	VBZ	0
only	only	RB	0
observed	observed	VBN	0
in	in	IN	0
response	response	NN	0
to	to	TO	0
mitogenic	mitogenic	VB	0
stimulation	stimulation	VBN	0
by	by	IN	0
Ras	Ras	NNP	0
.	.	.	0
We	We	PRP	0
have	have	VBP	0
also	also	RB	0
demonstrated	demonstrated	VBN	0
that	that	IN	0
the	the	DT	0
Elk-1	Elk-1	NNP	B-NP
and	and	CC	0
p35-c/ebpβ	p35-c/ebpβ	NN	B-NP
protein	protein	NN	I-NP
interact	interact	VBP	0
using	using	VBG	0
both	both	DT	0
in	in	IN	0
vitro	vitro	JJ	B-NP
GST-pulldown	GST-pulldown	JJ	I-NP
and	and	CC	0
in	in	IN	0
vivo	vivo	JJ	B-NP
coimmunoprecipitation	coimmunoprecipitation	JJ	I-NP
assay	assay	NN	I-NP
.	.	.	0
The	The	DT	0
in	in	IN	0
vivo	vivo	JJ	B-NP
interaction	interaction	NN	I-NP
,	,	,	0
however	however	RB	0
,	,	,	0
is	is	VBZ	0
dependent	dependent	JJ	0
on	on	IN	0
the	the	DT	0
presence	presence	NN	0
of	of	IN	0
activated	activated	JJ	0
Ras	Ras	NNP	0
.	.	.	0
Finally	Finally	RB	0
,	,	,	0
we	we	PRP	0
demonstrate	demonstrate	VBP	0
that	that	IN	0
the	the	DT	0
in	in	IN	0
vitro	vitro	JJ	B-NP
interaction	interaction	JJ	I-NP
domain	domain	NN	I-NP
of	of	IN	0
the	the	DT	0
two	two	CD	0
proteins	proteins	NNS	0
are	are	VBP	0
the	the	DT	0
ccaat/enhancer	ccaat/enhancer	NN	B-NP
binding	binding	JJ	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
protein	protein	NN	I-NP
beta	beta	NN	I-NP
c-terminal	c-terminal	NN	I-NP
domain	domain	NN	I-NP
and	and	CC	0
the	the	DT	0
elk-1	elk-1	NN	B-NP
n-terminal	n-terminal	NN	I-NP
domain	domain	NN	I-NP
.	.	.	0
These	These	DT	0
results	results	NNS	0
suggest	suggest	VBP	0
a	a	DT	0
new	new	JJ	0
mechanism	mechanism	NN	0
for	for	IN	0
serum	serum	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
response	response	NN	I-NP
element	element	NN	I-NP
transactivation	transactivation	NN	I-NP
,	,	,	0
where	where	WRB	0
a	a	DT	0
competent	competent	JJ	0
transcriptional	transcriptional	JJ	B-NP
complex	complex	NN	I-NP
consisting	consisting	VBG	0
of	of	IN	0
at	at	IN	0
least	least	JJS	0
serum	serum	NN	B-NP
response	response	NN	I-NP
factor	factor	NN	I-NP
,	,	,	0
TCF	TCF	NNP	B-NP
,	,	,	0
and	and	CC	0
p35-C	p35-C	CD	B-NP
/	/	CD	I-NP
EBPβ	EBPβ	JJ	I-NP
participate	participate	NN	0
in	in	IN	0
transactivation	transactivation	NN	B-NP
in	in	IN	0
response	response	NN	0
to	to	TO	0
Ras	Ras	NNP	0
.	.	.	0
To	To	TO	0
this	this	DT	0
point	point	NN	0
,	,	,	0
the	the	DT	0
tcf	tcf	NN	B-NP
family	family	NN	I-NP
member	member	NN	I-NP
have	have	VBP	0
been	been	VBN	0
thought	thought	VBN	0
to	to	TO	0
be	be	VB	0
the	the	DT	0
main	main	JJ	0
targets	targets	NNS	0
of	of	IN	0
Ras	Ras	NNP	0
signaling	signaling	VBG	0
to	to	TO	0
the	the	DT	0
serum	serum	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
response	response	NN	I-NP
element	element	NN	I-NP
,	,	,	0
and	and	CC	0
tcf	tcf	NN	B-NP
activation	activation	NN	I-NP
by	by	IN	0
Ras	Ras	NNP	0
has	has	VBZ	0
been	been	VBN	0
shown	shown	VBN	0
to	to	TO	0
result	result	VB	0
in	in	IN	0
serum	serum	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
response	response	NN	I-NP
element	element	NN	I-NP
transactivation	transactivation	NN	I-NP
[	[	-LRB-	0
16	16	CD	0
]	]	-RRB-	0
.	.	.	0
However	However	RB	0
,	,	,	0
we	we	PRP	0
show	show	VBP	0
that	that	IN	0
tcf	tcf	NN	B-NP
ras	ras	NNP	I-NP
activation	activation	NN	I-NP
alone	alone	RB	0
does	does	VBZ	0
not	not	RB	0
result	result	VB	0
in	in	IN	0
maximal	maximal	JJ	B-NP
SRE	SRE	NN	I-NP
transactivation	transactivation	NN	I-NP
,	,	,	0
but	but	CC	0
instead	instead	RB	0
,	,	,	0
is	is	VBZ	0
greatly	greatly	RB	0
enhanced	enhanced	VBN	0
in	in	IN	0
the	the	DT	0
presence	presence	NN	0
of	of	IN	0
p35-C	p35-C	NNP	B-NP
/	/	NNP	I-NP
EBPβ	EBPβ	NNP	I-NP
.	.	.	0
SRF	SRF	NNP	0
and	and	CC	0
TCF	TCF	NNP	0
have	have	VBP	0
been	been	VBN	0
shown	shown	VBN	0
to	to	TO	0
form	form	VB	0
a	a	DT	0
ternary	ternary	JJ	0
complex	complex	NN	0
at	at	IN	0
the	the	DT	0
SRE	SRE	NNP	0
in	in	IN	0
vitro	vitro	NN	0
.	.	.	0
We	We	PRP	0
as	as	RB	0
yet	yet	RB	0
have	have	VBP	0
not	not	RB	0
been	been	VBN	0
able	able	JJ	0
to	to	TO	0
observe	observe	VB	0
a	a	DT	0
ternary	ternary	JJ	0
complex	complex	NN	0
between	between	IN	0
SRF	SRF	NNP	0
and	and	CC	0
p35-C	p35-C	CD	0
/	/	CD	0
EBPβ	EBPβ	NN	0
at	at	IN	0
the	the	DT	0
SRE	SRE	NNP	0
in	in	IN	0
vitro	vitro	NN	0
.	.	.	0
The	The	DT	0
mechanisms	mechanisms	NNS	0
of	of	IN	0
SRE	SRE	NNP	0
transactivation	transactivation	VBD	0
described	described	VBN	0
above	above	RB	0
may	may	MD	0
help	help	VB	0
to	to	TO	0
explain	explain	VB	0
the	the	DT	0
in	in	IN	0
vitro	vitro	JJ	0
results	results	NNS	0
.	.	.	0
The	The	DT	0
C	C	$	0
/	/	CD	0
EBPβ	EBPβ	JJ	0
recognition	recognition	NN	0
site	site	NN	0
in	in	IN	0
the	the	DT	0
SRE	SRE	NNP	0
is	is	VBZ	0
a	a	DT	0
weak	weak	JJ	0
binding	binding	JJ	0
site	site	NN	0
[	[	-LRB-	0
25	25	CD	0
]	]	-RRB-	0
.	.	.	0
Upon	Upon	IN	0
ras-dependent	ras-dependent	NN	B-NP
activation	activation	NN	I-NP
signaling	signaling	JJ	0
pathways	pathways	NN	0
,	,	,	0
the	the	DT	0
presence	presence	NN	0
of	of	IN	0
p35-C	p35-C	CD	B-NP
/	/	CD	I-NP
EBPβ	EBPβ	NN	I-NP
at	at	IN	0
the	the	DT	0
serum	serum	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
response	response	NN	I-NP
element	element	NN	I-NP
would	would	MD	0
be	be	VB	0
stabilized	stabilized	VBN	0
due	due	JJ	0
to	to	TO	0
its	its	PRP$	0
strong	strong	JJ	0
protein-protein	protein-protein	JJ	B-NP
interaction	interaction	NN	I-NP
not	not	RB	0
only	only	RB	0
with	with	IN	0
serum	serum	NN	B-NP
response	response	NN	I-NP
factor	factor	NN	I-NP
,	,	,	0
as	as	IN	0
we	we	PRP	0
have	have	VBP	0
shown	shown	VBN	0
previously	previously	RB	0
[	[	-LRB-	0
23	23	CD	0
]	]	-RRB-	0
,	,	,	0
but	but	CC	0
also	also	RB	0
with	with	IN	0
Elk-1	Elk-1	CD	B-NP
.	.	.	0
It	It	PRP	0
is	is	VBZ	0
possible	possible	JJ	0
that	that	IN	0
p35-C	p35-C	NNP	B-NP
/	/	NNP	I-NP
EBPβ	EBPβ	NNP	I-NP
and	and	CC	0
serum	serum	NN	B-NP
response	response	NN	I-NP
factor	factor	NN	I-NP
are	are	VBP	0
not	not	RB	0
sufficient	sufficient	JJ	0
to	to	TO	0
form	form	VB	0
a	a	DT	0
ternary	ternary	JJ	B-NP
complex	complex	NN	I-NP
with	with	IN	0
the	the	DT	0
serum	serum	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
response	response	NN	I-NP
element	element	NN	I-NP
in	in	IN	0
vitro	vitro	NN	B-NP
,	,	,	0
but	but	CC	0
Elk-1	Elk-1	NNP	B-NP
may	may	MD	0
also	also	RB	0
be	be	VB	0
necessary	necessary	JJ	0
.	.	.	0
In	In	IN	0
addition	addition	NN	B-NP
,	,	,	0
it	it	PRP	0
is	is	VBZ	0
likely	likely	RB	0
that	that	IN	0
p35-C	p35-C	NNP	B-NP
/	/	NNP	I-NP
EBPβ	EBPβ	NNP	I-NP
,	,	,	0
Elk-1	Elk-1	NNP	B-NP
,	,	,	0
or	or	CC	0
both	both	DT	0
,	,	,	0
may	may	MD	0
need	need	VB	0
to	to	TO	0
be	be	VB	0
activated	activated	VBN	0
by	by	IN	0
one	one	CD	0
or	or	CC	0
more	more	RBR	0
multiprotein	multiprotein	JJ	B-NP
complex	complex	NN	I-NP
mapk	mapk	NN	I-NP
family	family	NN	I-NP
member	member	NN	I-NP
to	to	TO	0
form	form	VB	0
with	with	IN	0
serum	serum	NN	B-NP
response	response	NN	I-NP
factor	factor	NN	I-NP
at	at	IN	0
the	the	DT	0
serum	serum	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
response	response	NN	I-NP
element	element	NN	I-NP
.	.	.	0
further	further	JJ	B-NP
study	study	NN	I-NP
utilizing	utilizing	VBP	0
the	the	DT	0
information	information	NN	0
from	from	IN	0
the	the	DT	0
in	in	IN	0
vivo	vivo	JJ	B-NP
study	study	NN	I-NP
performed	performed	VBD	0
here	here	RB	0
may	may	MD	0
permit	permit	VB	0
us	us	PRP	0
to	to	TO	0
optimize	optimize	VB	0
the	the	DT	0
in	in	IN	0
vitro	vitro	JJ	B-NP
condition	condition	NN	I-NP
necessary	necessary	JJ	0
to	to	TO	0
observe	observe	VB	0
such	such	PDT	0
a	a	DT	0
multiprotein	multiprotein	JJ	B-NP
complex	complex	NN	I-NP
.	.	.	0
We	We	PRP	0
observe	observe	VBP	0
a	a	DT	0
direct	direct	JJ	0
interaction	interaction	NN	0
between	between	IN	0
ccaat/enhancer	ccaat/enhancer	NN	B-NP
binding	binding	JJ	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
protein	protein	NN	I-NP
beta	beta	NN	I-NP
and	and	CC	0
Elk-1	Elk-1	CD	B-NP
in	in	IN	0
a	a	DT	0
GST	GST	NN	B-NP
pulldown	pulldown	NN	I-NP
assay	assay	NN	I-NP
.	.	.	0
Another	Another	DT	0
ets	ets	JJ	B-NP
family	family	NN	I-NP
member	member	NN	I-NP
,	,	,	0
Ets-1	Ets-1	NNP	B-NP
,	,	,	0
has	has	VBZ	0
previously	previously	RB	0
been	been	VBN	0
shown	shown	VBN	0
to	to	TO	0
interact	interact	VB	0
with	with	IN	0
ccaat/enhancer	ccaat/enhancer	NN	B-NP
binding	binding	JJ	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
protein	protein	NN	I-NP
beta	beta	NN	I-NP
in	in	IN	0
vitro	vitro	NN	B-NP
[	[	-LRB-	0
26	26	CD	0
]	]	-RRB-	0
.	.	.	0
We	We	PRP	0
have	have	VBP	0
not	not	RB	0
directly	directly	RB	0
tested	tested	VBN	0
the	the	DT	0
ability	ability	NN	B-NP
of	of	IN	0
the	the	DT	0
other	other	JJ	0
TCF	TCF	NNP	B-NP
famlily	famlily	NN	0
members	members	NNS	0
,	,	,	0
SAP1	SAP1	NNP	B-NP
and	and	CC	0
SAP2	SAP2	NNP	B-NP
/	/	NNP	0
ERP	ERP	NNP	B-NP
/	/	NNP	I-NP
NET	NET	NNP	I-NP
,	,	,	0
to	to	TO	0
interact	interact	VB	0
with	with	IN	0
ccaat/enhancer	ccaat/enhancer	NN	B-NP
binding	binding	JJ	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
protein	protein	NN	I-NP
beta	beta	NN	I-NP
.	.	.	0
We	We	PRP	0
find	find	VBP	0
that	that	IN	0
the	the	DT	0
domain	domain	NN	0
of	of	IN	0
Elk-1	Elk-1	CD	B-NP
that	that	IN	0
interacts	interacts	NN	0
with	with	IN	0
ccaat/enhancer	ccaat/enhancer	NN	B-NP
binding	binding	JJ	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
protein	protein	NN	I-NP
beta	beta	NN	I-NP
is	is	VBZ	0
the	the	DT	0
ets	ets	JJ	B-NP
domain	domain	NN	I-NP
,	,	,	0
which	which	WDT	0
is	is	VBZ	0
conserved	conserved	VBN	0
among	among	IN	0
the	the	DT	0
other	other	JJ	0
tcf	tcf	NN	B-NP
family	family	NN	I-NP
member	member	NN	I-NP
[	[	-LRB-	0
16	16	CD	0
]	]	-RRB-	0
.	.	.	0
We	We	PRP	0
would	would	MD	0
therefore	therefore	RB	0
also	also	RB	0
expect	expect	VB	0
SAP1	SAP1	NNP	B-NP
and	and	CC	0
SAP2	SAP2	NNP	B-NP
/	/	NNP	0
ERP	ERP	NNP	B-NP
/	/	NNP	I-NP
NET	NET	NNP	I-NP
to	to	TO	0
interact	interact	VB	0
with	with	IN	0
ccaat/enhancer	ccaat/enhancer	NN	B-NP
binding	binding	JJ	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
protein	protein	NN	I-NP
beta	beta	NN	I-NP
.	.	.	0
Interestingly	Interestingly	RB	0
,	,	,	0
the	the	DT	0
in	in	IN	0
elk-1	elk-1	NN	B-NP
vivo	vivo	JJ	I-NP
interaction	interaction	NN	I-NP
and	and	CC	0
ccaat/enhancer	ccaat/enhancer	NN	B-NP
binding	binding	JJ	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
protein	protein	NN	I-NP
beta	beta	NN	I-NP
is	is	VBZ	0
dependent	dependent	JJ	0
on	on	IN	0
ras-dependent	ras-dependent	NN	B-NP
activation	activation	NN	I-NP
signaling	signaling	JJ	0
pathways	pathways	NN	0
.	.	.	0
The	The	DT	0
target	target	NN	B-NP
of	of	IN	0
the	the	DT	0
Ras	Ras	JJ	0
signaling	signaling	JJ	0
pathway	pathway	NN	0
is	is	VBZ	0
as	as	RB	0
yet	yet	RB	0
unknown	unknown	JJ	0
.	.	.	0
It	It	PRP	0
has	has	VBZ	0
been	been	VBN	0
shown	shown	VBN	0
that	that	IN	0
transfection	transfection	NN	B-NP
of	of	IN	0
activated	activated	JJ	0
ras	ras	NNP	B-NP
result	result	NN	I-NP
in	in	IN	0
thr235	thr235	NN	B-NP
phosphorylation	phosphorylation	NN	I-NP
(	(	-LRB-	0
numbering	numbering	NN	0
for	for	IN	0
human	human	JJ	0
protein	protein	NN	B-NP
)	)	-RRB-	0
in	in	IN	0
the	the	DT	0
ccaat/enhancer	ccaat/enhancer	NN	B-NP
binding	binding	JJ	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
protein	protein	NN	I-NP
beta	beta	NN	I-NP
c-terminal	c-terminal	NN	I-NP
domain	domain	NN	I-NP
,	,	,	0
and	and	CC	0
that	that	IN	0
Thr235	Thr235	NNP	B-NP
could	could	MD	0
be	be	VB	0
phosphorylated	phosphorylated	VBN	0
by	by	IN	0
a	a	DT	0
partially	partially	FW	0
purified	purified	VBN	B-NP
MAPK	MAPK	NN	I-NP
preparation	preparation	NN	I-NP
in	in	FW	0
vitro	vitro	NNP	B-NP
[	[	-LRB-	0
19	19	CD	0
]	]	-RRB-	0
.	.	.	0
We	We	PRP	0
have	have	VBP	0
also	also	RB	0
shown	shown	VBN	0
that	that	IN	0
this	this	DT	0
same	same	JJ	0
residue	residue	NN	0
is	is	VBZ	0
necessary	necessary	JJ	0
for	for	IN	0
Ras	Ras	NNP	B-NP
stimultion	stimultion	NN	I-NP
of	of	IN	0
the	the	DT	0
interaction	interaction	NN	0
between	between	IN	0
ccaat/enhancer	ccaat/enhancer	NN	B-NP
binding	binding	JJ	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
protein	protein	NN	I-NP
beta	beta	NN	I-NP
and	and	CC	0
serum	serum	NN	B-NP
response	response	NN	I-NP
factor	factor	NN	I-NP
.	.	.	0
Therefore	Therefore	RB	0
,	,	,	0
it	it	PRP	0
will	will	MD	0
be	be	VB	0
interesting	interesting	JJ	0
to	to	TO	0
determine	determine	VB	0
if	if	IN	0
this	this	DT	0
site	site	NN	0
is	is	VBZ	0
also	also	RB	0
critical	critical	JJ	0
for	for	IN	0
stimulation	stimulation	NN	0
of	of	IN	0
the	the	DT	0
interaction	interaction	NN	0
between	between	IN	0
ccaat/enhancer	ccaat/enhancer	NN	B-NP
binding	binding	JJ	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
protein	protein	NN	I-NP
beta	beta	NN	I-NP
and	and	CC	0
Elk-1	Elk-1	NNP	B-NP
.	.	.	0
Elk-1	Elk-1	NNP	B-NP
also	also	RB	0
has	has	VBZ	0
several	several	JJ	0
mapk	mapk	NN	B-NP
site	site	NN	I-NP
in	in	IN	0
its	its	PRP$	0
C-terminal	C-terminal	JJ	B-NP
domain	domain	NN	I-NP
,	,	,	0
and	and	CC	0
therefore	therefore	RB	0
this	this	DT	0
region	region	NN	0
could	could	MD	0
also	also	RB	0
be	be	VB	0
a	a	DT	0
target	target	NN	0
for	for	IN	0
Ras	Ras	NNP	0
.	.	.	0
We	We	PRP	0
are	are	VBP	0
currently	currently	RB	0
investigating	investigating	VBG	0
the	the	DT	0
mechanism	mechanism	NN	0
of	of	IN	0
the	the	DT	0
observed	observed	JJ	0
synergy	synergy	NN	B-NP
between	between	IN	0
Elk-1	Elk-1	NNP	B-NP
and	and	CC	0
p35-C	p35-C	NNP	B-NP
/	/	NNP	I-NP
EBPβ	EBPβ	NNP	I-NP
.	.	.	0
We	We	PRP	0
have	have	VBP	0
shown	shown	VBN	0
that	that	IN	0
ccaat/enhancer	ccaat/enhancer	NN	B-NP
binding	binding	JJ	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
protein	protein	NN	I-NP
beta	beta	NN	I-NP
interacts	interacts	NN	0
with	with	IN	0
the	the	DT	0
elk-1	elk-1	NN	B-NP
a-box	a-box	NN	I-NP
,	,	,	0
while	while	IN	0
serum	serum	NN	B-NP
response	response	NN	I-NP
factor	factor	NN	I-NP
has	has	VBZ	0
previously	previously	RB	0
been	been	VBN	0
shown	shown	VBN	0
to	to	TO	0
interact	interact	VB	0
with	with	IN	0
the	the	DT	0
B-box	B-box	JJ	B-NP
[	[	-LRB-	0
16	16	CD	0
]	]	-RRB-	0
.	.	.	0
Therefore	Therefore	RB	0
,	,	,	0
ccaat/enhancer	ccaat/enhancer	NN	B-NP
binding	binding	JJ	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
protein	protein	NN	I-NP
beta	beta	NN	I-NP
and	and	CC	0
serum	serum	NN	B-NP
response	response	NN	I-NP
factor	factor	NN	I-NP
interact	interact	NN	0
with	with	IN	0
two	two	CD	0
distinct	distinct	JJ	0
domains	domains	NN	0
of	of	IN	0
Elk-1	Elk-1	NNP	B-NP
,	,	,	0
as	as	RB	0
well	well	RB	0
as	as	RB	0
with	with	IN	0
each	each	DT	0
other	other	JJ	0
,	,	,	0
which	which	WDT	0
could	could	MD	0
allow	allow	VB	0
formation	formation	NN	0
of	of	IN	0
a	a	DT	0
complex	complex	NN	0
of	of	IN	0
the	the	DT	0
three	three	CD	0
transcription	transcription	CD	B-NP
factor	factor	NN	I-NP
.	.	.	0
This	This	DT	0
would	would	MD	0
create	create	VB	0
an	an	DT	0
active	active	JJ	0
transcriptional	transcriptional	JJ	B-NP
complex	complex	NN	I-NP
at	at	IN	0
the	the	DT	0
serum	serum	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
response	response	NN	I-NP
element	element	NN	I-NP
and	and	CC	0
result	result	NN	0
in	in	IN	0
enhanced	enhanced	JJ	0
transactivation	transactivation	NN	B-NP
.	.	.	0
It	It	PRP	0
is	is	VBZ	0
possible	possible	JJ	0
that	that	IN	0
the	the	DT	0
p35-C	p35-C	CD	B-NP
/	/	CD	I-NP
EBPβ-SRF-Elk-1	EBPβ-SRF-Elk-1	CD	I-NP
complex	complex	NN	I-NP
could	could	MD	0
interact	interact	VB	0
more	more	RBR	0
strongly	strongly	RB	0
with	with	IN	0
coactivator	coactivator	NN	B-NP
and	and	CC	0
/	/	NNP	0
or	or	CC	0
the	the	DT	0
basal	basal	JJ	B-NP
transcriptional	transcriptional	JJ	I-NP
machinery	machinery	NN	I-NP
than	than	IN	0
each	each	DT	0
individual	individual	JJ	B-NP
transcription	transcription	JJ	I-NP
factor	factor	NN	I-NP
.	.	.	0
It	It	PRP	0
has	has	VBZ	0
been	been	VBN	0
shown	shown	VBN	0
that	that	IN	0
serum	serum	NN	B-NP
response	response	NN	I-NP
factor	factor	NN	I-NP
,	,	,	0
TCF	TCF	NNP	B-NP
,	,	,	0
and	and	CC	0
ccaat/enhancer	ccaat/enhancer	NN	B-NP
binding	binding	JJ	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
protein	protein	NN	I-NP
beta	beta	NN	I-NP
can	can	MD	0
all	all	RB	0
interact	interact	VBN	0
with	with	IN	0
components	components	NNS	0
of	of	IN	0
transcriptional	transcriptional	JJ	B-NP
machinery	machinery	NN	I-NP
such	such	JJ	0
as	as	IN	0
p300	p300	NNP	B-NP
/	/	NNP	0
CBP	CBP	NNP	B-NP
,	,	,	0
SRC-1	SRC-1	NNP	B-NP
,	,	,	0
and	and	CC	0
TFII-I	TFII-I	NNP	B-NP
[	[	-LRB-	0
27	27	CD	0
,	,	,	0
28	28	CD	0
,	,	,	0
29	29	CD	0
,	,	,	0
30	30	CD	0
]	]	-RRB-	0
.	.	.	0
There	There	EX	0
is	is	VBZ	0
most	most	RBS	0
likely	likely	JJ	0
a	a	DT	0
large	large	JJ	0
protein	protein	NN	B-NP
complex	complex	NN	I-NP
assembled	assembled	VBN	0
at	at	IN	0
the	the	DT	0
serum	serum	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
response	response	NN	I-NP
element	element	NN	I-NP
composed	composed	VBN	0
of	of	IN	0
regulated	regulated	JJ	0
transcription	transcription	JJ	B-NP
factor	factor	NN	I-NP
,	,	,	0
coactivator	coactivator	NN	B-NP
,	,	,	0
and	and	CC	0
the	the	DT	0
basal	basal	JJ	B-NP
transcriptional	transcriptional	JJ	I-NP
machinery	machinery	NN	I-NP
,	,	,	0
resulting	resulting	VBG	0
in	in	IN	0
c-fos	c-fos	JJ	B-NP
gene	gene	NN	I-NP
rapid	rapid	JJ	I-NP
transcription	transcription	NN	I-NP
in	in	IN	0
response	response	NN	0
to	to	TO	0
mitogenic	mitogenic	VB	0
stimulation	stimulation	NN	0
.	.	.	0
Conclusions	Conclusions	NNS	0
This	This	DT	0
report	report	NN	0
demonstrates	demonstrates	VBZ	0
a	a	DT	0
new	new	JJ	0
model	model	NN	0
for	for	IN	0
c-fos	c-fos	NNP	B-NP
SRE	SRE	NNP	I-NP
activation	activation	NN	I-NP
in	in	IN	0
response	response	NN	0
to	to	TO	0
Ras-dependent	Ras-dependent	JJ	B-NP
signaling	signaling	JJ	0
pathways	pathways	NN	0
.	.	.	0
We	We	PRP	0
show	show	VBP	0
that	that	IN	0
serum	serum	NN	B-NP
response	response	NN	I-NP
factor	factor	NN	I-NP
,	,	,	0
Elk-1	Elk-1	NNP	B-NP
,	,	,	0
and	and	CC	0
p35-C	p35-C	CD	B-NP
/	/	CD	I-NP
EBPβ	EBPβ	NN	I-NP
are	are	VBP	0
all	all	DT	0
necessary	necessary	JJ	0
for	for	IN	0
serum	serum	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
response	response	NN	I-NP
element	element	NN	I-NP
maximal	maximal	JJ	I-NP
ras-stimulated	ras-stimulated	NN	I-NP
transactivation	transactivation	NN	I-NP
.	.	.	0
Materials	Materials	NNS	0
and	and	CC	0
Methods	Methods	NNP	0
Cell	Cell	NNP	0
Culture	Culture	NNP	0
and	and	CC	0
transfection	transfection	NN	B-NP
NIH	NIH	NNP	B-NP
3T3	3T3	FW	0
fibroblasts	fibroblasts	FW	0
(	(	-LRB-	0
from	from	IN	0
the	the	DT	0
American	American	NNP	0
Type	Type	NNP	B-NP
Culture	Culture	NNP	I-NP
Collection	Collection	NNP	I-NP
)	)	-RRB-	0
and	and	CC	0
cos-7	cos-7	NN	B-NP
cell	cell	NN	I-NP
(	(	-LRB-	0
kindly	kindly	RB	0
provided	provided	VBN	0
by	by	IN	0
Dr.	Dr.	NNP	B-NP
S.	S.	NNP	0
Hann	Hann	NNP	0
,	,	,	0
Vanderbilt	Vanderbilt	NNP	0
University	University	NNP	0
)	)	-RRB-	0
were	were	VBD	0
grown	grown	VBN	0
in	in	IN	0
Dulbecco	Dulbecco	NNP	0
's	's	POS	0
Modified	Modified	NNP	0
Eagle	Eagle	NNP	0
Medium	Medium	NNP	0
(	(	-LRB-	0
DMEM	DMEM	NNP	0
)	)	-RRB-	0
with	with	IN	0
10	10	CD	0
%	%	NN	0
calf	calf	NN	B-NP
serum	serum	NN	I-NP
(	(	-LRB-	0
Colorado	Colorado	NNP	0
Serum	Serum	NNP	0
Company	Company	NNP	0
)	)	-RRB-	0
,	,	,	0
0.22	0.22	CD	0
%	%	NN	0
sodium	sodium	NN	B-NP
bicarbonate	bicarbonate	NN	I-NP
,	,	,	0
4	4	CD	0
mM	mM	JJ	B-NP
L-glutamine	L-glutamine	NN	I-NP
,	,	,	0
25	25	CD	0
U	U	NNP	0
of	of	IN	0
penicillin	penicillin	JJ	B-NP
G	G	NNP	I-NP
sodium	sodium	NN	I-NP
per	per	FW	0
mL	mL	FW	0
,	,	,	0
and	and	CC	0
25	25	CD	0
mg	mg	NN	B-NP
of	of	IN	0
streptomycin	streptomycin	FW	0
per	per	FW	0
mL	mL	FW	0
.	.	.	0
cos-7	cos-7	NN	B-NP
cell	cell	NN	I-NP
transfection	transfection	NN	I-NP
were	were	VBD	0
performed	performed	VBN	0
by	by	IN	0
the	the	DT	0
calcium	calcium	JJ	B-NP
phosphate	phosphate	NN	I-NP
(	(	-LRB-	0
CaPO	CaPO	NNP	B-NP
4	4	CD	0
)	)	-RRB-	0
technique	technique	NN	0
[	[	-LRB-	0
31	31	CD	0
]	]	-RRB-	0
.	.	.	0
Cells	Cells	NNS	0
at	at	IN	0
60-70	60-70	CD	0
%	%	NN	0
confluence	confluence	NN	B-NP
were	were	VBD	0
exposed	exposed	VBN	0
to	to	TO	0
the	the	DT	0
calcium	calcium	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
phosphate	phosphate	NN	I-NP
4	4	CD	0
-DNA	-DNA	JJ	0
precipitate	precipitate	NN	0
for	for	IN	0
8	8	CD	0
h	h	NNS	0
.	.	.	0
The	The	DT	0
medium	medium	NN	0
was	was	VBD	0
removed	removed	VBN	0
and	and	CC	0
replaced	replaced	VBN	0
with	with	IN	0
complete	complete	JJ	0
medium	medium	NN	0
for	for	IN	0
36	36	CD	0
h	h	NN	0
before	before	IN	0
harvesting	harvesting	NN	0
.	.	.	0
NIH	NIH	NNP	B-NP
3T3	3T3	NNP	0
transfections	transfections	NN	0
were	were	VBD	0
performed	performed	VBN	0
using	using	VBG	0
NovaFector	NovaFector	JJ	0
(	(	-LRB-	0
Venn	Venn	NNP	0
Nova	Nova	NNP	0
)	)	-RRB-	0
or	or	CC	0
Trans-IT	Trans-IT	NNP	0
LT1	LT1	NNP	B-NP
(	(	-LRB-	0
PanVera	PanVera	NNP	B-NP
)	)	-RRB-	0
as	as	RB	0
described	described	VBN	0
by	by	IN	0
the	the	DT	0
manufacturer	manufacturer	NN	B-NP
.	.	.	0
For	For	IN	0
novafector	novafector	NN	B-NP
transfection	transfection	NN	I-NP
,	,	,	0
a	a	DT	0
6	6	CD	0
:	:	:	0
1	1	CD	0
ratio	ratio	NN	0
of	of	IN	0
NovaFector	NovaFector	JJ	0
:	:	:	0
DNA	DNA	NNP	B-NP
was	was	VBD	0
used	used	VBN	0
for	for	IN	0
each	each	DT	0
transfection	transfection	NN	B-NP
.	.	.	0
Cells	Cells	NNS	0
at	at	IN	0
60-70	60-70	CD	0
%	%	NN	0
confluence	confluence	NN	B-NP
were	were	VBD	0
exposed	exposed	VBN	0
to	to	TO	0
the	the	DT	0
NovaFector	NovaFector	JJ	0
:	:	:	0
DNA	DNA	NNP	B-NP
complex	complex	NN	I-NP
for	for	IN	0
6-7	6-7	CD	0
h	h	NN	0
in	in	IN	0
serum	serum	NN	B-NP
and	and	CC	0
antibiotic	antibiotic	JJ	B-NP
free	free	JJ	I-NP
medium	medium	NN	I-NP
.	.	.	0
After	After	IN	0
the	the	DT	0
incubation	incubation	NN	0
,	,	,	0
an	an	DT	0
equal	equal	JJ	0
volume	volume	NN	0
of	of	IN	0
DMEM	DMEM	NNP	B-NP
containing	containing	VBG	0
20	20	CD	0
%	%	NN	0
calf	calf	NN	B-NP
serum	serum	NN	I-NP
was	was	VBD	0
added	added	VBN	0
for	for	IN	0
24	24	CD	0
h	h	NN	0
,	,	,	0
bringing	bringing	VBG	0
the	the	DT	0
calf	calf	JJ	B-NP
serum	serum	NN	I-NP
final	final	JJ	I-NP
concentration	concentration	NN	I-NP
to	to	TO	0
10	10	CD	0
%	%	NN	0
.	.	.	0
Cells	Cells	NNS	0
were	were	VBD	0
then	then	RB	0
serum	serum	VB	B-NP
deprived	deprived	VBN	0
for	for	IN	0
36-40	36-40	CD	0
h	h	NN	0
in	in	IN	0
DMEM	DMEM	NNP	B-NP
supplemented	supplemented	NN	I-NP
as	as	IN	0
above	above	JJ	0
except	except	IN	0
containing	containing	VBG	0
0.5	0.5	CD	0
%	%	NN	0
calf	calf	NN	B-NP
serum	serum	NN	I-NP
before	before	IN	0
harvesting	harvesting	NN	0
.	.	.	0
For	For	IN	0
transit-lt1	transit-lt1	NN	B-NP
transfection	transfection	NN	I-NP
,	,	,	0
a	a	DT	0
6	6	CD	0
:	:	:	0
1	1	CD	0
ratio	ratio	NN	0
of	of	IN	0
TransIT-LT1	TransIT-LT1	CD	B-NP
:	:	:	0
DNA	DNA	NNP	B-NP
was	was	VBD	0
used	used	VBN	0
in	in	IN	0
each	each	DT	0
transfection	transfection	NN	B-NP
.	.	.	0
Cells	Cells	NNS	0
at	at	IN	0
60-70	60-70	CD	0
%	%	NN	0
confluence	confluence	NN	B-NP
were	were	VBD	0
exposed	exposed	VBN	0
to	to	TO	0
the	the	DT	0
TransIT-LT1	TransIT-LT1	NNP	B-NP
:	:	:	0
DNA	DNA	NNP	B-NP
complex	complex	NN	I-NP
for	for	IN	0
8	8	CD	0
h	h	NN	0
in	in	IN	0
complete	complete	JJ	0
medium	medium	NN	0
plus	plus	CC	0
freshly	freshly	RB	0
added	added	VBD	0
30	30	CD	0
mg	mg	CD	B-NP
/	/	CD	I-NP
mL	mL	JJ	I-NP
polymyxin	polymyxin	JJ	I-NP
B	B	NN	I-NP
antibiotic	antibiotic	NN	I-NP
[	[	-LRB-	0
32	32	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
medium	medium	NN	0
was	was	VBD	0
then	then	RB	0
removed	removed	VBN	0
and	and	CC	0
replaced	replaced	VBN	0
with	with	IN	0
complete	complete	JJ	0
medium	medium	NN	0
for	for	IN	0
24	24	CD	0
h.	h.	NN	B-NP
cell	cell	NN	I-NP
were	were	VBD	0
then	then	RB	0
serum	serum	VB	B-NP
deprived	deprived	VBN	0
in	in	IN	0
DMEM	DMEM	NNP	B-NP
containing	containing	VBG	0
0.5	0.5	CD	0
%	%	NN	0
calf	calf	NN	B-NP
serum	serum	NN	I-NP
for	for	IN	0
36-40	36-40	CD	0
h	h	NN	0
before	before	IN	0
harvesting	harvesting	NN	0
.	.	.	0
Cell	Cell	NN	0
extracts	extracts	NNS	0
were	were	VBD	0
prepared	prepared	VBN	0
and	and	CC	0
chloramphenicol	chloramphenicol	NN	B-NP
acetyl	acetyl	NN	I-NP
transferase	transferase	NN	I-NP
(	(	-LRB-	0
CAT	CAT	NNP	B-NP
)	)	-RRB-	0
assays	assays	NN	0
were	were	VBD	0
performed	performed	VBN	0
on	on	IN	0
extracts	extracts	NNS	0
containing	containing	VBG	0
equivalent	equivalent	JJ	0
cell	cell	NN	B-NP
protein	protein	NN	I-NP
as	as	IN	0
previously	previously	RB	0
described	described	VBN	0
[	[	-LRB-	0
33	33	CD	0
]	]	-RRB-	0
.	.	.	0
An	An	DT	0
internal	internal	JJ	B-NP
control	control	NN	I-NP
plasmid	plasmid	NN	I-NP
to	to	TO	0
measure	measure	VB	0
transfection	transfection	JJ	B-NP
efficiency	efficiency	NN	I-NP
could	could	MD	0
not	not	RB	0
be	be	VB	0
used	used	VBN	0
because	because	IN	0
ccaat/enhancer	ccaat/enhancer	NN	B-NP
binding	binding	JJ	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
protein	protein	NN	I-NP
beta	beta	NN	I-NP
regulates	regulates	VBZ	0
transcrption	transcrption	VBN	0
from	from	IN	0
the	the	DT	0
control	control	NN	B-NP
plasmid	plasmid	NN	I-NP
,	,	,	0
and	and	CC	0
thus	thus	RB	0
makes	makes	VBZ	0
the	the	DT	0
internal	internal	JJ	B-NP
control	control	NN	I-NP
invalid	invalid	NN	I-NP
.	.	.	0
Therefore	Therefore	RB	0
,	,	,	0
the	the	DT	0
transfection	transfection	NN	B-NP
were	were	VBD	0
repeated	repeated	VBN	0
multiple	multiple	JJ	0
times	times	NNS	0
to	to	TO	0
control	control	VB	0
for	for	IN	0
variability	variability	NN	0
in	in	IN	0
transfection	transfection	JJ	B-NP
efficiency	efficiency	NN	I-NP
.	.	.	0
Plasmids	Plasmids	VBG	0
The	The	DT	0
pGAL4	pGAL4	NNP	B-NP
and	and	CC	0
pG5CAT	pG5CAT	CD	0
plasmids	plasmids	NNS	0
were	were	VBD	0
obtained	obtained	VBN	0
from	from	IN	0
the	the	DT	0
Mammalian	Mammalian	NNP	B-NP
MATCHMAKER	MATCHMAKER	NNP	I-NP
Two-Hybrid	Two-Hybrid	NNP	I-NP
Assay	Assay	NNP	I-NP
Kit	Kit	NNP	I-NP
(	(	-LRB-	0
CLONTECH	CLONTECH	NNP	B-NP
)	)	-RRB-	0
.	.	NNP	0
pGAL4-SRF	pGAL4-SRF	NNP	B-NP
was	was	VBD	0
constructed	constructed	VBN	0
as	as	IN	0
previously	previously	RB	0
described	described	VBN	0
[	[	-LRB-	0
23	23	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
SRE-CAT	SRE-CAT	JJ	B-NP
reporter	reporter	NN	I-NP
gene	gene	NN	I-NP
was	was	VBD	0
constructed	constructed	VBN	0
as	as	IN	0
previously	previously	RB	0
described	described	VBN	0
[	[	-LRB-	0
22	22	CD	0
]	]	-RRB-	0
.	.	.	0
pGST-p35-C	pGST-p35-C	NN	B-NP
/	/	NN	I-NP
EBPβ	EBPβ	NNP	I-NP
was	was	VBD	0
constructed	constructed	VBN	0
by	by	IN	0
inserting	inserting	VBG	0
the	the	DT	0
1,739	1,739	JJ	0
bp	bp	JJ	B-NP
EcoRI	EcoRI	JJ	I-NP
fragment	fragment	NN	I-NP
from	from	IN	0
pRSETB-EFII	pRSETB-EFII	NNP	B-NP
[	[	-LRB-	0
34	34	CD	0
]	]	-RRB-	0
into	into	IN	0
EcoRI	EcoRI	JJ	B-NP
cut	cut	NN	I-NP
pGEX-4T-1	pGEX-4T-1	NNP	I-NP
(	(	-LRB-	0
Amersham-Pharmacia	Amersham-Pharmacia	NNP	B-NP
)	)	-RRB-	0
.	.	.	0
pGST-p20-C	pGST-p20-C	NN	B-NP
/	/	NN	I-NP
EBPβ	EBPβ	NNP	I-NP
was	was	VBD	0
constructed	constructed	VBN	0
by	by	IN	0
inserting	inserting	VBG	0
the	the	DT	0
581	581	CD	0
bp	bp	CD	B-NP
BamHI	BamHI	JJ	I-NP
/	/	CD	I-NP
EcoRI	EcoRI	JJ	I-NP
fragment	fragment	NN	I-NP
from	from	IN	0
pRsetA-LIP	pRsetA-LIP	NNP	B-NP
[	[	-LRB-	0
34	34	CD	0
]	]	-RRB-	0
into	into	IN	0
similarly	similarly	FW	0
digested	digested	FW	0
pGEX4T-1.	pGEX4T-1.	FW	0
pcDNA3	pcDNA3	NN	B-NP
/	/	FW	0
Elk-1	Elk-1	NN	B-NP
(	(	-LRB-	I-NP
1-209	1-209	NNP	I-NP
)	)	-RRB-	I-NP
and	and	CC	0
pcDNA3	pcDNA3	NNP	B-NP
/	/	NNP	0
Elk-1	Elk-1	NNP	B-NP
(	(	-LRB-	I-NP
1-140	1-140	NNP	I-NP
)	)	-RRB-	I-NP
were	were	VBD	0
constructed	constructed	VBN	0
by	by	IN	0
using	using	VBG	0
the	the	DT	0
Erase-A-Base	Erase-A-Base	JJ	B-NP
system	system	NN	I-NP
(	(	-LRB-	0
Promega	Promega	NNP	B-NP
)	)	-RRB-	0
with	with	IN	0
pcDNA3	pcDNA3	CD	B-NP
/	/	CD	0
Elk-1	Elk-1	CD	B-NP
(	(	-LRB-	0
gift	gift	NN	0
of	of	IN	0
J.	J.	NNP	0
Schwartz	Schwartz	NNP	0
,	,	,	0
Univ.	Univ.	NNP	B-NP
of	of	IN	0
Michigan	Michigan	NNP	B-NP
)	)	-RRB-	0
as	as	RB	0
described	described	VBN	0
by	by	IN	0
the	the	DT	0
manufacturer.	manufacturer.	NNP	B-NP
pcDNA3.1	pcDNA3.1	NNP	B-NP
/	/	NNP	0
His-p35-C	His-p35-C	NNP	B-NP
/	/	NNP	I-NP
EBPβ	EBPβ	NNP	I-NP
was	was	VBD	0
constructed	constructed	VBN	0
by	by	IN	0
inserting	inserting	VBG	0
an	an	DT	0
1,739	1,739	JJ	0
bp	bp	JJ	B-NP
EcoRI	EcoRI	JJ	I-NP
fragment	fragment	NN	I-NP
from	from	IN	0
pRSETB-EFII	pRSETB-EFII	JJ	B-NP
into	into	IN	0
an	an	DT	0
EcoRI	EcoRI	JJ	B-NP
cut	cut	NN	I-NP
pcDNA3.1	pcDNA3.1	NN	I-NP
/	/	FW	0
HisC	HisC	NN	B-NP
vector	vector	NN	I-NP
(	(	-LRB-	0
Invitrogen	Invitrogen	NNP	B-NP
)	)	-RRB-	0
.	.	.	0
CMV-LAP	CMV-LAP	NNP	B-NP
was	was	VBD	0
a	a	DT	0
gift	gift	NN	0
of	of	IN	0
U.	U.	NNP	B-NP
Schibler	Schibler	NNP	I-NP
(	(	-LRB-	0
Univ.	Univ.	NNP	B-NP
of	of	IN	0
Geneva	Geneva	NNP	0
,	,	,	0
Geneva	Geneva	NNP	0
,	,	,	0
Switzerland	Switzerland	NNP	B-NP
)	)	-RRB-	0
and	and	CC	0
cmv-ra	cmv-ra	NN	B-NP
was	was	VBD	0
a	a	DT	0
gift	gift	NN	0
of	of	IN	0
E.	E.	NNP	0
Ruley	Ruley	NNP	0
(	(	-LRB-	0
Vanderbilt	Vanderbilt	NNP	0
Univ.	Univ.	NNP	0
)	)	-RRB-	0
.	.	.	0
Analysis	Analysis	NN	0
of	of	IN	0
ELK-1	ELK-1	NNP	B-NP
and	and	CC	0
C	C	NNP	B-NP
/	/	NN	I-NP
EBPβ	EBPβ	NN	I-NP
interaction	interaction	NN	I-NP
in	in	FW	0
vitro	vitro	NNP	B-NP
GST-p35-C	GST-p35-C	NN	I-NP
/	/	NN	I-NP
EBPβ	EBPβ	NN	I-NP
,	,	,	0
GST-p20-C	GST-p20-C	NNP	B-NP
/	/	NNP	I-NP
EBPβ	EBPβ	NNP	I-NP
,	,	,	0
or	or	CC	0
gstorc4	gstorc4	NN	B-NP
alone	alone	RB	0
was	was	VBD	0
produced	produced	VBN	0
in	in	IN	0
BL21	BL21	NNP	B-NP
E.	E.	NNP	I-NP
Coli	Coli	NNP	I-NP
by	by	IN	0
80	80	CD	0
mM	mM	JJ	B-NP
isopropyl-β-D-thiogalactopyranoside	isopropyl-β-D-thiogalactopyranoside	NN	I-NP
(	(	-LRB-	0
IPTG	IPTG	NNP	0
)	)	-RRB-	0
induction	induction	JJ	B-NP
overnight	overnight	JJ	0
at	at	IN	0
37°C	37°C	CD	0
.	.	.	0
Cells	Cells	NNS	0
were	were	VBD	0
harvested	harvested	VBN	0
by	by	IN	0
centrifugation	centrifugation	NN	B-NP
and	and	CC	0
washed	washed	VBD	0
once	once	RB	0
with	with	IN	0
phosphate-buffered	phosphate-buffered	JJ	B-NP
saline	saline	NN	I-NP
(	(	-LRB-	0
phosphate	phosphate	NN	B-NP
buffered	buffered	NN	I-NP
saline	saline	JJ	I-NP
)	)	-RRB-	0
containing	containing	VBG	0
the	the	DT	0
following	following	JJ	0
protease	protease	JJ	B-NP
inhibitor	inhibitor	NN	I-NP
:	:	:	0
2	2	CD	0
mg	mg	CD	B-NP
/	/	CD	I-NP
ml	ml	JJ	I-NP
aprotinin	aprotinin	NN	I-NP
,	,	,	0
2	2	CD	0
mg	mg	CD	B-NP
/	/	CD	I-NP
ml	ml	JJ	I-NP
leupeptin	leupeptin	NN	I-NP
,	,	,	0
2	2	CD	0
mM	mM	JJ	0
phenylmethylsulfonyl	phenylmethylsulfonyl	JJ	B-NP
fluoride	fluoride	NN	I-NP
(	(	-LRB-	0
phenylmethylsulfonylfluoride	phenylmethylsulfonylfluoride	NN	B-NP
)	)	-RRB-	0
,	,	,	0
and	and	CC	0
0.2	0.2	CD	0
mM	mM	JJ	B-NP
pepstatin	pepstatin	NN	I-NP
.	.	.	0
The	The	DT	0
bacteria	bacteria	NNS	0
were	were	VBD	0
lysed	lysed	VBN	0
by	by	IN	0
sonication	sonication	NN	B-NP
at	at	IN	0
4	4	CD	0
oC	oC	NN	B-NP
in	in	IN	0
phosphate	phosphate	NN	B-NP
buffered	buffered	NN	I-NP
saline	saline	JJ	I-NP
containing	containing	VBG	0
the	the	DT	0
protease	protease	JJ	B-NP
inhibitor	inhibitor	NN	I-NP
described	described	VBD	0
above	above	RB	0
.	.	.	0
Triton	Triton	NNP	B-NP
X-100	X-100	NNP	I-NP
was	was	VBD	0
added	added	VBN	0
to	to	TO	0
a	a	DT	0
final	final	JJ	B-NP
concentration	concentration	NN	I-NP
of	of	IN	0
0.1	0.1	CD	0
%	%	NN	0
,	,	,	0
followed	followed	VBN	0
by	by	IN	0
gentle	gentle	JJ	0
mixing	mixing	NN	0
for	for	IN	0
30	30	CD	0
min	min	NN	B-NP
at	at	IN	0
4°C	4°C	CD	0
.	.	.	0
The	The	DT	0
lysate	lysate	NN	B-NP
was	was	VBD	0
clarified	clarified	VBN	0
at	at	IN	0
12,000	12,000	CD	0
×	×	CD	0
g	g	NN	0
for	for	IN	0
10	10	CD	0
min	min	NN	B-NP
at	at	IN	0
4°C	4°C	CD	0
.	.	.	0
The	The	DT	0
supernatant	supernatant	NN	B-NP
was	was	VBD	0
gently	gently	RB	0
mixed	mixed	VBN	0
with	with	IN	0
glutathione-sepharose	glutathione-sepharose	JJ	B-NP
bead	bead	NN	I-NP
(	(	-LRB-	0
Amersham-Pharmacia	Amersham-Pharmacia	NNP	B-NP
)	)	-RRB-	0
at	at	IN	0
4°C	4°C	CD	0
for	for	IN	0
30	30	CD	0
min	min	NN	B-NP
.	.	.	0
Beads	Beads	RB	0
containing	containing	VBG	B-NP
gst	gst	NN	I-NP
protein	protein	NN	I-NP
were	were	VBD	0
collected	collected	VBN	0
by	by	IN	0
low	low	JJ	0
speed	speed	NN	B-NP
centrifugation	centrifugation	NN	I-NP
,	,	,	0
followed	followed	VBN	0
by	by	IN	0
three	three	CD	0
successive	successive	JJ	0
washes	washes	NN	0
with	with	IN	0
phosphate	phosphate	NN	B-NP
buffered	buffered	NN	I-NP
saline	saline	JJ	I-NP
containing	containing	VBG	0
0.1	0.1	CD	0
%	%	NN	0
Triton	Triton	NNP	B-NP
X-100	X-100	NNP	I-NP
and	and	CC	0
the	the	DT	0
protease	protease	JJ	B-NP
inhibitor	inhibitor	NN	I-NP
described	described	VBD	0
above	above	RB	0
.	.	.	0
The	The	DT	0
ELK-1	ELK-1	NNP	B-NP
,	,	,	0
ELK-1	ELK-1	NNP	B-NP
(	(	-LRB-	I-NP
1-209	1-209	NNP	I-NP
)	)	-RRB-	I-NP
,	,	,	0
ELK-1	ELK-1	NNP	B-NP
(	(	-LRB-	I-NP
1-140	1-140	NNP	I-NP
)	)	-RRB-	I-NP
,	,	,	0
and	and	CC	0
elk-1(89-428)	elk-1(89-428)	NN	B-NP
protein	protein	NN	I-NP
were	were	VBD	0
transcribed	transcribed	JJ	0
and	and	CC	0
translated	translated	VBN	0
in	in	IN	0
vitro	vitro	NN	B-NP
using	using	VBG	0
the	the	DT	0
TNT	TNT	NNP	B-NP
T7	T7	NN	I-NP
coupled	coupled	FW	0
reticulocyte	reticulocyte	NN	B-NP
lysate	lysate	NN	I-NP
system	system	NN	I-NP
(	(	-LRB-	0
Promega	Promega	NNP	B-NP
)	)	-RRB-	0
according	according	VBG	0
to	to	TO	0
the	the	DT	0
manufacture	manufacture	NN	0
's	's	POS	0
instruction	instruction	NN	B-NP
.	.	.	0
Translated	Translated	VBN	0
proteins	proteins	NNS	0
were	were	VBD	0
radiolabeled	radiolabeled	VBN	0
with	with	IN	0
the	the	DT	0
EXPRE	EXPRE	FW	0
35S	35S	FW	0
35S	35S	FW	0
protein	protein	FW	0
labeling	labeling	VBG	B-NP
mix	mix	NN	I-NP
(	(	-LRB-	0
Dupont	Dupont	NNP	B-NP
NEN	NEN	NNP	I-NP
)	)	-RRB-	0
.	.	.	0
The	The	DT	0
GST-pulldown	GST-pulldown	JJ	B-NP
assay	assay	NN	I-NP
was	was	VBD	0
done	done	VBN	0
as	as	IN	0
previously	previously	RB	0
described	described	VBN	0
[	[	-LRB-	0
22	22	CD	0
]	]	-RRB-	0
.	.	.	0
co-immunoprecipitation	co-immunoprecipitation	NN	B-NP
cos-7	cos-7	NN	I-NP
cell	cell	NN	I-NP
were	were	VBD	0
harvested	harvested	VBN	0
in	in	IN	0
phosphate	phosphate	NN	B-NP
buffered	buffered	NN	I-NP
saline	saline	JJ	I-NP
containing	containing	VBG	0
0.1	0.1	CD	0
mM	mM	JJ	B-NP
sodium	sodium	NN	I-NP
vanadata	vanadata	NN	I-NP
and	and	CC	0
collected	collected	VBN	0
by	by	IN	0
low	low	JJ	0
speed	speed	NN	B-NP
centrifugation	centrifugation	NN	I-NP
.	.	.	0
Cells	Cells	NNS	0
were	were	VBD	0
resuspended	resuspended	VBN	0
in	in	IN	0
lysis	lysis	JJ	B-NP
buffer	buffer	NN	I-NP
(	(	-LRB-	0
10	10	CD	0
mm	mm	NN	B-NP
tri	tri	NNP	I-NP
(	(	-LRB-	0
pH	pH	NNP	B-NP
7.5	7.5	CD	0
)	)	-RRB-	0
,	,	,	0
1	1	CD	0
mM	mM	JJ	B-NP
EDTA	EDTA	NNP	I-NP
,	,	,	0
50	50	CD	0
mM	mM	JJ	B-NP
NaCl	NaCl	NN	I-NP
,	,	,	0
0.25	0.25	CD	0
%	%	NN	0
Nonidet	Nonidet	NNP	B-NP
P-40	P-40	NNP	I-NP
,	,	,	0
1	1	CD	0
mM	mM	JJ	B-NP
PMSF	PMSF	NNP	I-NP
,	,	,	0
1	1	CD	0
mg	mg	NN	B-NP
of	of	IN	0
aprotinin	aprotinin	JJ	0
/	/	NNP	0
mL	mL	NNP	0
,	,	,	0
0.1	0.1	CD	0
mM	mM	JJ	B-NP
sodium	sodium	JJ	I-NP
vanadate	vanadate	NN	I-NP
,	,	,	0
10	10	CD	0
mM	mM	JJ	B-NP
sodium	sodium	JJ	I-NP
molybdate	molybdate	NN	I-NP
,	,	,	0
and	and	CC	0
10	10	CD	0
mM	mM	JJ	B-NP
β-glycerol	β-glycerol	JJ	I-NP
phosphate	phosphate	NN	I-NP
)	)	-RRB-	0
and	and	CC	0
lysed	lysed	NN	B-NP
by	by	IN	0
sonication	sonication	NN	B-NP
with	with	IN	0
a	a	DT	0
microtip	microtip	NN	B-NP
on	on	IN	0
setting	setting	VBG	0
2	2	CD	0
and	and	CC	0
20	20	CD	0
%	%	NN	0
duty	duty	NN	B-NP
cycle	cycle	NN	I-NP
for	for	IN	0
10	10	CD	0
s	s	NNS	0
.	.	.	0
After	After	IN	0
clarification	clarification	NN	B-NP
by	by	IN	0
centrifugation	centrifugation	NN	B-NP
at	at	IN	0
12,000	12,000	CD	0
×	×	CD	0
g	g	NN	0
for	for	IN	0
10	10	CD	0
min	min	NN	B-NP
,	,	,	0
the	the	DT	0
cell	cell	NN	0
extract	extract	NN	0
was	was	VBD	0
incubated	incubated	VBN	0
with	with	IN	0
t7	t7	NN	B-NP
tag	tag	NN	I-NP
antibody	antibody	NN	I-NP
(ab)-agarose	(ab)-agarose	NN	I-NP
bead	bead	NN	I-NP
(	(	-LRB-	0
Novagen	Novagen	NNP	B-NP
)	)	-RRB-	0
for	for	IN	0
2	2	CD	0
h	h	NNS	0
.	.	.	0
The	The	DT	0
beads	beads	NN	0
were	were	VBD	0
collected	collected	VBN	0
by	by	IN	0
low	low	JJ	0
speed	speed	NN	B-NP
centrifugation	centrifugation	NN	I-NP
and	and	CC	0
washed	washed	VBD	0
3	3	CD	0
times	times	NNS	0
with	with	IN	0
lysis	lysis	JJ	B-NP
buffer	buffer	NN	I-NP
.	.	.	0
All	All	DT	0
steps	steps	NNS	0
were	were	VBD	0
performed	performed	VBN	0
at	at	IN	0
4°C	4°C	CD	0
.	.	.	0
After	After	IN	0
washing	washing	NN	0
,	,	,	0
the	the	DT	0
beads	beads	NN	0
were	were	VBD	0
boiled	boiled	VBN	0
for	for	IN	0
5	5	CD	0
min	min	NN	B-NP
in	in	IN	0
Laemmli	Laemmli	NNP	B-NP
sample	sample	NN	I-NP
buffer	buffer	NN	I-NP
.	.	.	0
Immunoblots	Immunoblots	VBG	0
The	The	DT	0
samples	samples	NNS	0
from	from	IN	0
the	the	DT	0
coimmunoprecipitation	coimmunoprecipitation	NN	B-NP
described	described	VBD	0
above	above	RB	0
were	were	VBD	0
analyzed	analyzed	VBN	0
by	by	IN	0
electrophoresi	electrophoresi	NN	B-NP
on	on	IN	0
an	an	DT	0
SDS-12	SDS-12	JJ	B-NP
%	%	NN	0
polyacrylamide	polyacrylamide	NN	B-NP
gel	gel	NN	I-NP
for	for	IN	0
3	3	CD	0
h	h	NN	0
at	at	IN	0
160	160	CD	0
V.	V.	CD	0
The	The	DT	0
gel	gel	NN	B-NP
was	was	VBD	0
equilibrated	equilibrated	VBN	0
in	in	IN	0
transfer	transfer	NN	B-NP
buffer	buffer	NN	I-NP
(	(	-LRB-	0
33	33	CD	0
mM	mM	JJ	0
Tris	Tris	JJ	B-NP
base	base	NN	I-NP
,	,	,	0
192	192	CD	0
mM	mM	JJ	B-NP
glycine	glycine	NN	I-NP
,	,	,	0
20	20	CD	0
%	%	NN	0
methanol	methanol	NN	0
)	)	-RRB-	0
for	for	IN	0
15	15	CD	0
min	min	NN	B-NP
before	before	IN	0
transfer	transfer	NN	0
of	of	IN	0
proteins	proteins	NNS	0
to	to	TO	0
Immobilon-P	Immobilon-P	JJ	B-NP
membrane	membrane	NN	I-NP
(	(	-LRB-	0
Millipore	Millipore	NNP	B-NP
Corp.	Corp.	NNP	0
)	)	-RRB-	0
.	.	.	0
After	After	IN	0
transfer	transfer	NN	0
,	,	,	0
an	an	DT	0
immunoblot	immunoblot	NN	B-NP
was	was	VBD	0
performed	performed	VBN	0
as	as	RB	0
described	described	VBN	0
previously	previously	RB	0
[	[	-LRB-	0
22	22	CD	0
]	]	-RRB-	0
.	.	.	0
A	A	DT	0
1	1	CD	0
:	:	:	0
2000	2000	CD	0
dilution	dilution	NN	0
of	of	IN	0
anti-Elk-1	anti-Elk-1	NNP	B-NP
Ab	Ab	NNP	I-NP
(	(	-LRB-	0
Santa	Santa	NNP	0
Cruz	Cruz	NNP	0
Biotechnology	Biotechnology	NNP	0
)	)	-RRB-	0
and	and	CC	0
a	a	DT	0
1	1	CD	0
:	:	:	0
5000	5000	CD	0
dilution	dilution	NN	0
of	of	IN	0
goat	goat	JJ	B-NP
anti-rabbit	anti-rabbit	JJ	I-NP
secondary	secondary	JJ	I-NP
Ab	Ab	NNP	I-NP
(	(	-LRB-	0
Roche	Roche	NNP	0
molecular	molecular	JJ	B-NP
biochemical	biochemical	JJ	I-NP
)	)	-RRB-	0
were	were	VBD	0
used	used	VBN	0
.	.	.	0
The	The	DT	0
secondary	secondary	JJ	B-NP
Ab	Ab	NNP	I-NP
was	was	VBD	0
detected	detected	VBN	0
using	using	VBG	0
SuperSignal	SuperSignal	JJ	B-NP
Chemiluminescent	Chemiluminescent	NNP	I-NP
Substrate	Substrate	NNP	I-NP
(	(	-LRB-	0
Pierce	Pierce	NNP	0
)	)	-RRB-	0
.	.	.	0
amino	amino	JJ	B-NP
acid	acid	NN	I-NP
abbreviation	abbreviation	NN	I-NP
,	,	,	0
amino	amino	JJ	0
acid	acid	NN	B-NP
;	;	:	0
antibody	antibody	NN	B-NP
,	,	,	0
antibody	antibody	NN	B-NP
;	;	:	0
bp	bp	CD	B-NP
,	,	,	0
base	base	NN	B-NP
pair	pair	NN	I-NP
;	;	:	0
calcium	calcium	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
phosphate	phosphate	NN	I-NP
4	4	CD	0
,	,	,	0
calcium	calcium	JJ	B-NP
phosphate	phosphate	NN	I-NP
;	;	:	0
ccaat/enhancer	ccaat/enhancer	NN	B-NP
binding	binding	JJ	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
protein	protein	NN	I-NP
beta	beta	NN	I-NP
,	,	,	0
CCAAT-enhancer	CCAAT-enhancer	JJ	B-NP
binding	binding	JJ	0
protein-beta	protein-beta	NN	B-NP
;	;	:	0
CAT	CAT	NNP	0
,	,	,	0
chloramphenicol	chloramphenicol	NN	B-NP
acetyl	acetyl	NN	I-NP
transferase	transferase	NN	I-NP
;	;	:	0
DMEM	DMEM	NNP	B-NP
,	,	,	0
Dulbecco	Dulbecco	NNP	0
's	's	POS	0
Modified	Modified	NNP	0
Eagle	Eagle	NNP	0
Medium	Medium	NNP	0
;	;	:	0
gstorc4	gstorc4	NN	B-NP
,	,	,	0
glutathione-S-transferase	glutathione-S-transferase	JJ	B-NP
;	;	:	0
mitogen	mitogen	NN	B-NP
activated	activated	VBN	I-NP
protein	protein	NN	I-NP
kinase	kinase	NN	I-NP
,	,	,	0
activated	activated	VBN	B-NP
protein	protein	NN	I-NP
kinase	kinase	NN	I-NP
mitogen	mitogen	NN	I-NP
;	;	:	0
phosphate	phosphate	NN	B-NP
buffered	buffered	NN	I-NP
saline	saline	JJ	I-NP
,	,	,	0
phosphate	phosphate	NN	B-NP
buffered	buffered	FW	0
saline	saline	FW	0
;	;	:	0
phenylmethylsulfonylfluoride	phenylmethylsulfonylfluoride	NN	B-NP
,	,	,	0
phenylmethylsulfonyl	phenylmethylsulfonyl	JJ	B-NP
fluoride	fluoride	NN	I-NP
;	;	:	0
serum	serum	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
response	response	NN	I-NP
element	element	NN	I-NP
,	,	,	0
serum	serum	JJ	B-NP
response	response	NN	I-NP
element	element	NN	I-NP
;	;	:	0
serum	serum	NN	B-NP
response	response	NN	I-NP
factor	factor	NN	I-NP
,	,	,	0
serum	serum	JJ	B-NP
response	response	NN	I-NP
factor	factor	NN	I-NP
;	;	:	0
TCF	TCF	NNP	B-NP
,	,	,	0
ternary	ternary	JJ	B-NP
complex	complex	JJ	I-NP
factor	factor	NN	I-NP
.	.	.	0
